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Abstract 
Background 
Real-time modelling is an essential component of the public health response to an outbreak of 
pandemic influenza in the United Kingdom. A model for epidemic reconstruction based on 
realistic epidemic surveillance data has been developed but needs enhancing to provide 
spatially disaggregated epidemic estimates whilst ensuring real-time implementation is 
feasible. 
Objectives 
To advance state-of-the-art real-time pandemic modelling by: 
• developing an existing epidemic model to capture spatial variation in transmission; 
• devising efficient computational algorithms for the provision of timely statistical 
analysis; 
• incorporating the above in freely available software; 
Methods 
Markov chain Monte Carlo (MCMC) is used to derive Bayesian statistical inference using 
2009 pandemic data from two candidate modelling approaches: a parallel-region (PR) 
approach, splitting the pandemic into non-interacting epidemics occurring in spatially disjoint 
regions; and a meta-region (MR) approach, treating the country as a single meta-population 
with long-range contact rates informed by census data on commuting. Model discrimination 
is performed through posterior mean deviance statistics alongside more practical 
considerations. 
 In a real-time context, the use of Sequential Monte Carlo (SMC) algorithms to carry 
out real time analyses is investigated as an alternative to MCMC, using simulated data 
designed to sternly test both algorithms. SMC-derived analyses are compared against “gold-
standard” MCMC-derived inferences in terms of estimation quality and computational 
burden. 
Results 
The PR approach provides a better, timelier, fit to the epidemic data. Estimates of pandemic 
quantities of interest are consistent across approaches, and, in the PR approach, across 
regions (e.g. 𝑅" is consistently estimated to be 1.76-1.80, dropping by 43%-50% during an 
over-summer school holiday). 
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An SMC approach is developed that required some tailoring to tackle a sudden 
“shock” in the data resulting from a pandemic intervention. This semi-automated SMC 
algorithm outperforms MCMC, both in terms of precision of estimates and their timely 
provision. 
Software implementing all findings has been developed and installed within PHE with 
key staff trained in its use. 
Limitations 
The PR model lacks the predictive power to forecast the spread of infection in the early 
stages of a pandemic, whereas the MR model may be limited by its dependence on 
commuting data to describe transmission routes. 
 As demand for resources increases in a severe pandemic, data from GPs and on 
hospitalisations may become unreliable or biased. 
 The SMC algorithm developed is semi-automated, some statistical literacy is required 
to achieve optimal performance. 
Conclusions 
Following the study objectives, timely, spatially disaggregate, real-time pandemic inference 
is feasible and an implementing system has been developed that assumes data as per 
pandemic preparedness plans. 
Future Work 
Modelling studies investigating: the impact of pandemic interventions (e.g. vaccination and 
school closure); the utility of alternative data sources (e.g. internet searches) to augment 
traditional surveillance; the correct handling of test sensitivity and specificity in serological 
data, propagating this uncertainty into the real-time modelling.  
Study Registration 
ISRCTN40334843 
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This work was supported by the National Institute for Health Research (HTA 
Project:11/46/03), DDA supported by the UK Medical Research Council (Unit Programme 
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Scientific summary 
Background 
The United Kingdom (UK) National Risk Register lists an outbreak of pandemic influenza as 
the largest risk faced by the UK outside of acts of terrorism. A prompt public health response 
to a pandemic, therefore, is vital if the effects of the pandemic are to be mitigated. A 
business-critical component of such a response is real-time epidemic modelling of the 
outbreak. As an epidemic progresses, real-time modelling should gradually refine our 
knowledge about the epidemic and, in particular, the burden it will place on healthcare 
services. The model should also be able to act as a simulator, allowing for the prospective 
examination and evaluation of the impact of any proposed epidemic interventions. 
Real-time modelling of an ongoing pandemic is, however, not a straightforward task. 
The model is a tool for statistical analysis of epidemic surveillance data. Model parameters 
should be progressively informed as data become available over time providing increasingly 
accurate assessments and prediction of the epidemic evolution. However, as experienced in 
responding to the 2009 “swine flu” (A/H1N1pdm virus) outbreak, real life epidemic 
surveillance data are frequently far messier than anticipated, containing contamination, noise 
and biases that are not always straightforward to foresee. Additionally, epidemics are rarely 
left to play out naturally. Public health interventions designed either to contain transmission 
or to relieve the burden placed on healthcare services have the potential to alter drastically 
our perception of a pandemic or, as in 2009, to interrupt the patterns observed in key data 
streams. These problems are addressed by using data from multiple sources, so that the 
different data types can compliment each other to eliminate noise and/or bias. 
A modelling framework must, therefore, be able to accommodate this wealth of 
different data types (typically arriving at daily intervals) and to do so in a timely fashion. It 
must also be robust to interventions and be able to provide analyses stratified by age groups 
and geographical location as required by policymakers. Any such model is likely to be highly 
complex and computationally challenging. 
After 2009, a model was developed that could incorporate a number of different types 
of data but did not allow for spatial stratification. The model was also relatively costly to run 
in real-time, as it was implemented using a technique for statistical computation called 
Markov Chain Monte Carlo (MCMC). To this point, the model developed had only ever been 
used in the retrospective analysis of an entire epidemic, not for real-time purposes. While 
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MCMC is useful in epidemic reconstruction, it is inefficient for real-time use, as, when new 
data arrive, it involves the re-analysis of the entire dataset. The ideal method needs, instead, 
to be sequential so that only the incoming data are used to update the analyses. Sequential 
Monte Carlo (SMC) techniques provide such an alternative approach. 
Objectives 
The central objective of this study is to advance the state of the art of real-time modelling of 
influenza epidemics and to provide a tool to monitor and predict the development of an 
ongoing pandemic outbreak. These advancements involve: 
• Investigating spatial modelling of epidemics to understand how best to account for 
regionally varying epidemic activity. Two candidate approaches are proposed and 
examined through the analysis of pandemic surveillance data from 2009. In particular, 
the strengths and weaknesses of each approach are examined to assess prospectively 
their potential utility in a future outbreak. 
• Building capacity in terms of the different types and increasing volume of data that 
can be used for real-time modelling. 
• Improving the efficiency with which real-time statistical inference can be made. 
In light of the above, a suite of software is produced, to achieve the above objectives, 
designed to provide support to national public health bodies in the event of a pandemic and 
tailored to the specific requirements of Public Health England (PHE), the responsible public 
health body in England. 
 
Methods 
Two candidate extensions to the existing epidemic model to track accurately a spatially 
diverse epidemic are proposed. The first approach, labelled the parallel-region (PR) approach, 
assumes that the epidemic is already established in each region by the time the modelling is 
initiated. From this point on, inter-region transmission can be considered to be negligible and 
the epidemics evolve in each region independently, though they will still share some 
characteristics. Spatially varying parameters, estimated separately for each region, are those 
depending on population behaviour and composition: the parameters that govern healthcare 
seeking behaviour; the initial seeding; the reproductive number 𝑅", the average number of 
secondary infections caused by a single infection in a fully susceptible population. 
The second approach, labelled the meta-region (MR) approach, uses census data on 
commuting behaviour to generate rates of movement between the different regions. Here, the 
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country is thought of as a single meta-region, with a population stratified by both age and 
location. The commuting data inform the relative rates of contact between individuals of each 
of the strata. There are a number of competing sub-hypotheses within this approach. These 
regard the effects of density dependence on contact rates, whether it is appropriate to assume 
individuals commute at random, and the importance of the initial seeding of infection. There 
will be a preliminary phase of model choice that will identify the relative performance of the 
model under each combination of these assumptions. 
These two methods are implemented to reconstruct the 2009 pandemic. Data include a 
time series of general practice (GP) consultation data, a short time series of virologically 
confirmed cases (found through initial attempts at tracing contacts of early infections), 
virological swabbing data and serological sampling data. The GP consultation data, derived 
from syndromic surveillance, are counts of individuals reporting a collection of symptoms, 
known as influenza-like illness (ILI). These data therefore contain a significant proportion of 
individuals who are consulting for non-pandemic illnesses, contaminating the data. The 
degree of contamination is identified by the virological swabbing data, where a small sub-
sample of individuals consulting their GP give swab samples for testing. The tests will 
indicate the presence/absence of the pandemic infection. Together, the GP consultation data 
and the virological swabbing data give a time series that is linked to the pattern of pandemic 
infection. The serological data come from the testing of blood sera samples taken during the 
pandemic and tested for the presence of immunity-conferring antibodies. This informs the 
levels of cumulative incidence, giving scale to the pattern of infection estimated from the GP 
data. Each data component is therefore vital in disentangling the underlying epidemic 
dynamics. In future pandemics, it is anticipated that surveillance data of each of these types 
will be enriched. Additionally, hospitalisation data will be available from all NHS trust 
hospitals, recording all admissions and, in particular, admissions requiring intensive care, of 
patients with the pandemic infection. 
As an epidemic reconstruction, the spatial analysis is implemented using MCMC. 
In a real-time monitoring context, however, it is necessary to develop and test an 
alternative algorithm to allow for the computationally efficient iteration of epidemic analyses. 
Starting with a “basic” SMC approach taken from literature, a number of algorithmic 
developments are proposed to cope with data simulated to correspond to a reasonable “worst-
case” epidemic scenario. Here, it is assumed that a public health intervention drastically 
disrupts the temporal pattern of the observed data and tests the ability of this iterative 
procedure to respond and adapt appropriately, providing reliable assessment of the epidemic 
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dynamics. The performance of the SMC algorithm is contrasted against the “gold standard” 
MCMC in terms of both the quality of the resulting estimates and computational efficiency.  
 
Results 
Spatial	Modelling	
Results show that both the PR and MR approaches are able to reconstruct the epidemic 
dynamics well, with the PR model providing a better fit to the data than all variants of the 
MR model. Additionally, the PR approach offers computational benefits, as it can exploit 
parallel computing, and be implemented in a fraction of the time of the MR approach. 
However, the PR approach does require significant epidemic activity to have occurred in each 
region for reliable estimation. If epidemic prediction is required in the early stages of a 
pandemic, the MR approach might be more useful. Within the MR approach, strong density 
dependent effects are found in contact rates between individuals, i.e. the chance of two 
people meeting is inversely proportional to the population size of the region in which they 
interact. Key model parameters that influence transmission are consistent across both PR and 
MR approaches, with, in particular 𝑅" consistently being estimated to be around 1.8. We are 
also able to estimate the drop in contact due to the over-summer school holidays. Contact 
rates among 5-14 year-olds fell to 0.6%-0.7% of their term time value, leading to a drop in 𝑅" 
of 43%-50%. 
 
Computational	Efficiency	
In terms of the SMC algorithm to sequentially update estimates as new data become 
available, in the majority of cases, a fairly straightforward SMC implementation taken from 
literature would suffice. However, sequential estimation becomes more problematic when the 
newly observed data are highly informative, as in the situation where a “shock” to the 
surveillance data is introduced to mimic the effect of a public health intervention. In this case, 
the SMC algorithm requires very careful construction to ensure it retains the capacity to 
accurately track the epidemic. An algorithm is pieced together that is semi-automated to 
minimise the computational effort required to update the analyses. In a moderately complex 
example, in the immediate aftermath of the intervention, the SMC method even outperforms 
the MCMC providing more reliable estimates and, with only moderate parallelisation (of the 
kind that most modern desktops are more than capable), SMC will prove faster to implement. 
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 All of the above models and algorithms have been incorporated into software that is 
now available for use by PHE in the event of a pandemic. Key PHE personnel are receiving 
training in its use, which, for the foreseeable future will continue to be offered on an ongoing 
basis.  
Conclusions 
The project divides neatly into two components: developing the modelling methodology to 
provide information to policymakers at the spatial resolution they require; and developing the 
statistical computing methodology to make robust and timely inference. In terms of the 
spatial modelling, the PR approach is the most suited approach for real-time epidemic 
monitoring, even though it has little predictive power early in the epidemic. This shows that 
either the effects of inter-region transmission are transient, or the available commuting data 
do not characterise the movement of individuals between regions particularly well. As far as 
the computational methodology is concerned, in the real-time context, sequential methods for 
analysis have been shown to be equally adept at providing inference as the more established 
MCMC, but with a considerable computational advantage. All of the findings have been 
encoded into software. 
 The research recommendations arising out of this work are 
1. To understand the impact of public health interventions. Here interventions involving 
school closure and the provision of a service to relieve the burden placed upon GPs 
have been considered and the model has been accordingly adapted. However, 
investigation of the modelling adaptations required to incorporate vaccination uptake 
and effects of antivirals (amongst others) would allow the assessment of these 
policies, both prospectively and retrospectively. It is anticipated that adaptations to 
the transmission component of the model to account for such measures would be 
reasonably straightforward, but to accommodate the data that would inform these 
adaptations would be more complex. 
2. To investigate the utility of alternative sources of epidemic surveillance. The 
statistical analysis of the epidemic is reliant upon surveillance data on the uptake of 
healthcare services (GP consultations, hospitalisations). In a widespread and/or severe 
pandemic, these resources could be severely stretched; hospital beds may not be 
available and GPs appointment books may be full. At this point, the data generated 
from these sources may become unreliable. As mentioned in point 1, data on vaccine 
uptake and antiviral prescriptions administered could potentially help to fill the 
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knowledge gap, but there are alternative influenza surveillance mechanisms that could 
be exploited and these should be investigated. Could Internet searches for key 
influenza terms be useful? Or sales of thermometers? Simplistic modelling studies to 
investigate these exist, but there is a real gap in the use of this kind of data in a real-
world example. 
3. To account properly for the uncertainty in serological results. It has been shown that 
serological data are particularly informative to the kind of modelling effort 
undertaken in this work. However, the sensitivity and specificity of the testing process 
is rarely considered, due to uncertainty as to precisely what level of antibodies 
constitutes long-term immunity to a virus. Proper handling of the uncertainty in these 
data, as well as their timely provision during a pandemic is essential. 
 
[2122 words] 
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Plain English summary 
In the event of an outbreak of pandemic influenza in England, Public Health England (PHE) 
has the role of providing up-to-the-moment epidemic assessments to policymakers. To do 
this, PHE has to make sense of epidemic surveillance data, which are typically incomplete, 
biased and/or contaminated, and use them to make statements about the present epidemic 
situation and its likely future path, including estimation of the burden placed on the NHS, and 
the assessment of the efficacy of proposed interventions. 
 This is the role of real-time epidemic modelling. A mathematical representation of the 
ongoing epidemic is developed and used in combination with available epidemic data to 
produce estimates of key epidemic features and the epidemic trajectory. 
The work in this project has enhanced PHE’s capacity for carrying out real-time 
modelling by: 
• Adapting an existing epidemic model to produce region-specific epidemic forecasts, 
increasing its utility to policymakers. Hypotheses regarding how to most 
appropriately encapsulate transmission of disease within and between regions were 
assessed both on their fit to data and on their ease of implementation. 
• Developing algorithms, building on the latest developments in statistical computation 
to allow epidemic analyses to be updated in a timely fashion as the epidemic unfolds. 
• Establishing a system for analysis of a future pandemic in accord with data scheduled 
to be available under PHEs strategy for pandemic surveillance, incorporating software 
and training to key PHE staff. 
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 1 Background  
Each year, the United Kingdom (UK) government publishes a document entitled the 
‘National Risk Register of Civil Emergencies’. The latest edition of the register lists the 
outbreak of a pandemic influenza virus to be the highest priority non-terrorism risk faced by 
the UK population.1 This highlights the importance of the country being in a high state of 
preparedness for such an outbreak. A key component of any protocol governing the public 
health response to an outbreak is a plan to monitor and predict the progress of a pandemic in 
real-time. 
During the 2009 outbreak of pandemic A/H1N1 influenza much attention was 
devoted to the problem of capturing the epidemic dynamics through real-time modelling. The 
aim of such modelling was to provide up-to-the-moment assessments of the state of the 
epidemic, as well as to make predictions of its future course, all based upon continually 
updating streams of information. The models used are mathematical constructs: systems of 
equations designed to approximate epidemic dynamics, describing the changes over time in 
the numbers of people within a population who are susceptible to infection, the number 
currently infected and the number who are presently immune. These equations are governed 
by a few key (hitherto unknown) quantities known as parameters that usually represent some 
physical characteristic of the epidemic (e.g., the average duration of infection, or relative 
rates of contact between members of relevant population groups). To enable assessment of 
the current state of the epidemic and its future evolution, values for these parameters need to 
be identified that are consistent with epidemic data. In addition, the uncertainty in the 
parameter values needs to be properly reflected in such assessments. To make formal, 
statistical, estimation of model parameters, models can often be simplified to ensure that 
estimates can be derived from the available data, computational resources and expertise. 
More generally, as seen in research focused on the evaluation of in-pandemic mitigation 
strategies,2, 3 parameter estimates have been obtained on a more ad hoc basis, by using the 
models and assumed ranges of parameter values to simulate epidemic scenarios. A selection 
of these parameter values is then retained based on some informal comparison between the 
corresponding simulated epidemics and the observed data. This type of approach is common 
to the literature on real-time modelling prior to 2009, in which the proposed methodologies 
are either heavily reliant upon an idealised set of circumstances and/or ad hoc estimation 
methods.4 
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Bayesian statistical epidemic models provide a natural, rigorous, framework for the 
incorporation of relevant contemporaneous surveillance data into the modelling process, 
alongside collateral information that may be available from other sources. These have been 
used in the context of real-time monitoring for other infectious diseases. For SARS, models 
have been proposed and applied for real-time estimation where the focus is on the 
reproductive number,5-7 a key epidemic characteristic defined to be the average number of 
secondary infections caused by a single infection within a fully susceptible population, often 
denoted 𝑅". A more complex Bayesian approach is utilised in an application to data 
stemming from the avian influenza epidemic in the UK poultry industry.8 Here the 
availability of individual-level data and the use of computationally intensive Bayesian 
techniques make it possible to carry out inference on the transmission dynamics, rather than 
merely the reproductive number. A similar model has been formulated within the Bayesian 
statistical paradigm to provide real-time estimates of the time-evolving effective reproductive 
number 𝑅"(𝑡) for a generic emerging disease,9 an approach that has since been applied to an 
A/H7N9 outbreak in China and subsequently extended.10, 11 
However, the modelling approaches above have typically used a single data stream 
providing direct data on the number of new cases of an infectious disease over time. This is 
also the case in the context of the 2009 outbreak in Singapore,12 where a real time reporting 
system for influenza-like illness (ILI) in sentinel general practices was established, and the 
resulting data were used to predict the epidemic in real time. In practice, as illustrated by the 
2009 outbreak in the UK, direct data are seldom available and, more likely, multiple sources 
of data exist, each indirectly informing the epidemic development, each subject to possible 
sources of bias. This calls for more involved complex epidemic modelling that can synthesise 
the information held within a range of data sources to compensate for the lack of direct 
observation of the infection process. As a result of this, real-time modelling in the UK in the 
face of the 2009 A/H1N1pdm outbreak proved to be more demanding and more intricate than 
had been anticipated.13 
In response to the 2009 pandemic in England, two approaches to real-time modelling 
were developed.14, 15 In the first,14 the authors present a framework for the real-time 
assessment of the effectiveness and cost-effectiveness of vaccination strategies, considering 
the whole of England. Embedded inside a cost-effectiveness model is an age and risk group 
structured deterministic mass-action SEIR (Susceptible, Exposed, Infectious, Recovered) 
transmission model, parameterised in terms of an age-specific force of infection i.e. the rate at 
which susceptible individuals acquire infection. Model parameters are estimated by a hybrid 
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of ad hoc approaches using as data a scaled version of the estimates of the number of 
symptomatic cases routinely produced by the Health Protection Agency (from 2011, Public 
Health England) (HPA) during the outbreak.16 Uncertainty in key parameters (e.g. 𝑅") is 
generated by sampling values of each parameter from a range or distribution to form a 
‘scenario’ from each combination of parameter values. Results from each scenario are 
compared to the scaled estimates and only the best-fitting 1% of the 60,000 realisations are 
retained to simulate future incidence and evaluate, with epidemiological uncertainty, the 
impact of different vaccination strategies on severe outcomes. 
In the second approach,15 data were more directly utilised within a Bayesian statistical 
framework. The basic modelling features resemble those used to measure the effects of 
school closure as a strategy for epidemic mitigation in Hong Kong.17 The primary difference 
is in the data used, where, instead of using counts of case confirmations alone, an array of 
different datasets were combined: age- and region-stratified data on GP consultations for 
ILI;18 virological positivity data from individuals reporting symptoms of ILI available 
through the Royal College of General Practitioners (RCGP) surveillance network and the 
Regional Microbiology Network (RMN) of the HPA; virological case confirmations from the 
early part of the epidemic; data on the seropositivity of sera samples taken before and during 
the 2009 pandemic and held by the Weekly Returns Service of the RCGP (see Section 3.1.1 
and Appendix 1 for more details).19 This work, however, considered only the London region. 
After the 2009 experience, two main issues were left unresolved. The first is the development 
of a spatial characterisation of the epidemic. This would need to be carried out at a 
geographical level fine enough to ensure homogeneous epidemic activity within each 
geographical unit, yet coarse enough to guarantee that the available data in each unit has a 
sufficiently informative sample size. The second issue is the need to accommodate the greater 
wealth of epidemic surveillance data supposedly available in future pandemics.20  
Both developments pose a challenge to existing modelling approaches. In terms of the 
Bayesian approach,15 the challenge is to extend the model structure and increase the volume 
of data to be assimilated into an already complex model in a sufficiently timely fashion for 
analysis to be feasible in real-time. This requires the development of more computationally 
efficient methods for Bayesian inference.  
1.1 Computational Methods 
The Bayesian approach is based on a computational technique known as Markov 
chain-Monte Carlo (MCMC).21 MCMC can be computationally burdensome when estimation 
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and prediction of an evolving epidemic are needed in real time. Every time new data become 
available, MCMC re-analyses the data in its entirety, requiring possibly millions of 
evaluations of the model. This is computationally costly and limiting to the speed at which 
results can be obtained. 
Methods to approximate the estimation procedure exist, either by replacing the model 
with a more-readily evaluated proxy,22 or by approximating the Bayesian approach.23 A more 
appropriate alternative to MCMC are Sequential Monte Carlo (SMC) methods.24-26 The use 
of such methods to analyse epidemic data is relatively common,11,27 yet analyses with a real-
time focus are rare,12 and those using a synthesis of numerous types of data do not exist.  
A further complication, not considered in the existing literature, is the need to accommodate 
the impact that public health interventions might have on the surveillance data underpinning 
the real-time analysis. As infection becomes more widespread, healthcare facilities become 
harder to access with those in need of healthcare channelled elsewhere. Any effective real-
time computational approach has to cope with the sudden shocks, unforeseen in some cases, 
that interventions might generate on the time course of the surveillance data.  
1.2 Outline 
The work reported here will expand upon an existing framework for statistical epidemic 
modelling,15 increasing its complexity to allow for spatial heterogeneity in transmission. Two 
competing spatial modelling approaches are examined (see Sections 3.2 and 4.1), to 
investigate how epidemic activity in different regions can be most efficiently and accurately 
estimated. This increased complexity and the extra dimension added to each of the epidemic 
datasets, add to the computational burden. A general algorithm for Bayesian statistical 
inference in such a scenario is developed and tested on a suite of synthetic pandemic data, 
incorporating the presence of ‘shocks’ in surveillance data arising from public health 
interventions (see Sections 3.6 and 4.2). The report concludes with a discussion (Section 5) 
and recommendations for future research (Section 6).
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2 Study Objectives 
The central objective of this study has been to advance the state of the art of real-time 
modelling of influenza epidemics and to provide a useful tool that can be used to monitor and 
predict the development of an ongoing pandemic outbreak. This advancement involves: 
• Accounting for spatial heterogeneity in transmission. This may be done through the 
modelling of separate, non-interacting but parametrically linked epidemics in spatially 
disjoint regions of a country, or through further stratification of the population 
according to location. 
• Building capacity in terms of the different types and increasing volume of data that 
can be used for real-time modelling. 
• Improving the efficiency with which real-time statistical inference can be made. 
• Developing a real-time inferential system that is robust to likely pandemic mitigation 
or treatment interventions. 
 
A suite of software has been produced, to achieve the above objectives, to provide 
support to national public health bodies in the event of a pandemic and tailored to the specific 
requirements of PHE, the responsible public health body in England. 
Initially, there was also a component of this research promising support to the HPA (now 
PHE) in the event of a pandemic in their real-time production of estimates and projections of 
the healthcare burden attributable to the pandemic. Such an outbreak did not occur over the 
duration of the study and this component of the project has thus been disregarded in the 
report. 
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3 Methods 
 
We shall begin by describing (Sections 3.1 and 3.2) the modelling approaches used in this 
work. In Section 3.3 we will examine the data types that PHE currently envisage being 
available, at some stage during a pandemic, for inclusion in the analysis. This section also 
discusses how the structure of the available data from 2009 helped determine the precise 
parameterisation of the real-time model. Together these will inform the spatial modelling 
study.  
 Section 3.5 provides an introduction to Bayesian inference and Section 3.6 discusses 
the MCMC and SMC methods. Section 3.6 in particular contains a significant amount of 
technical detail, including the tuning of a number of algorithmic components necessary to 
achieve timely inference, and may be omitted by the reader not interested in such detail. 
 
3.1 Modelling Methodology: Single-Region Model 
The starting point for the investigation in this study is the model and analysis of Birrell et 
al.15 Here, information from multiple sources is integrated into a composite model including: 
• An age-structured dynamic transmission component; 
• A disease component; 
• A component describing the mechanism of symptom reporting to healthcare facilities. 
A schematic model representation is given in Figure 1. Transmission in the SEIR model is 
governed by a time-and-age varying force of infection that is dependent upon the population 
structure, the transmissibility of the virus, the mixing patterns between population strata and 
the expected time spent in the E and I states. In the disease model layer, a proportion, ϕ, of 
the newly exposed individuals develop febrile symptoms. In the reporting model layer, 
further proportions of these symptomatic individuals consult their GP and/or have their 
symptoms officially confirmed through a virologically positive swab result. 
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Figure 1 A schematic diagram of the model. Adapted from Birrell et al. (2011).15 
 
Ideally, direct data on the number of new infections would be available, and in studies of 
modelling methodology this type of data are often assumed.11 However, more realistically, 
surveillance datasets are noisy and record events (such as GP consultations, see Section 
3.3.1) that occur some time later than the infection. Specifically for influenza, disease 
reporting is frequently through syndromic surveillance, where non-disease specific symptoms 
are reported. Instead of reporting influenza infections, the reporting is of patients suffering 
with ILI. Therefore, data from such sources include contamination from patients carrying 
infections other than the pathogen of interest. This adds greater complexity to the task of 
disentangling the underlying disease incidence from the available information, particularly as 
this contamination is likely to vary substantially during the pandemic. To identify the disease 
incidence, these noisy consultation data are combined with information on virological 
positivity from complimentary surveillance systems (see Figure 1 and Section 3.3). When 
multiple time series datasets are available, data on events occurring as close as possible to the 
time of infection should be preferred as they will be more informative. Alternatively, data 
arising as a result of severe symptoms are also valuable: severity is a property of the virus 
and so the proportion of cases that appear in data will be more stable over time. 
 The equations governing the epidemic dynamics are found in Appendix 1: Single-
Region model dynamics. 
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3.2 Modelling Methodology: Multi-region models 
The single-region transmission model of Figure 1 and Appendix 1 is extended to 
accommodate the evident spatial heterogeneity in the 2009 A/H1N1 pandemic data in two 
ways: by using a parallel-region (PR) approach or by using a meta-region (MR) approach.28 
These will be introduced in the two following sub-sections. 
3.2.1 The parallel-region (PR) model 
In the PR modelling approach, the spatially heterogeneous epidemic is assumed to be 
composed of a number of smaller epidemics occurring in parallel within each spatial unit, 
with no direct interaction (specifically no transmission) between regions. The rationale here 
is that the purpose of the real-time model is to monitor the pandemic once infection is 
widespread. By such a time, it is reasonable to assume that long-range inter-region 
transmission will be negligible in comparison to that occurring within each region. 
The parallel epidemics are still jointly modelled, however, as there is sharing of 
information on a number of model parameters set to be the same in each region. These 
parameters are typically those representing biological characteristics of the virus (mean 
infectious period, proportion symptomatic etc). Additionally, the mixing patterns are assumed 
to exhibit no regional variation. Appendix 1 presents a system of equations governing single-
region dynamics. This system is driven by two key quantities: the reproductive number, 𝑅"; 
and the initial state of the system, defined by a parameter giving the initial number of 
infective individuals, 𝐼". These are region specific parameters (𝑅",6, and 𝐼",6, 𝑟 = 1,… , 𝑅) as 
they are functions of both the regional population and the virus. Together, these parameters 
account for the different timing of the pandemic activity in each region. 
The system of dynamic equations given in Equation (8) of Appendix 1 applies within 
each spatial unit, and so needs little modification. 
3.2.2 The meta-region (MR) model 
In the MR modelling approach, regions are assumed connected such that transmission is 
possible between individuals resident in different regions. Here, we look at the country as a 
whole and treat it as a metapopulation of 𝑅 regions. Therefore, we can generalise the notation 
in the system of Equations (8) in Appendix 1 so that the index 𝑎 now takes values over the 
range 1, . . . , 𝑅𝐴. It is therefore necessary to define (𝑅𝐴 × 𝑅𝐴) contact matrices, 𝚷(𝑡>), 𝑘 =1,… , 𝐾, that describe the rates at which individuals of the various (region- and age-defined) 
strata come into contact. In the single-region and PR models, this matrix describes the rates at 
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which individuals of the various age groups interact, and was informed by UK data collected 
as part of the POLYMOD study (see Equation (10) and relevant text).29 In this expanded 
matrix, the entries that correspond to within-region contacts resemble the POLYMOD-based 
matrices. However, entries corresponding to inter-region interactions are typically of a lower 
order of magnitude, as people interact less frequently with people living in a different 
geographic region. These rates of contact are derived from census data on daily commuter 
movements between regions. The details of how, at the 𝑘th timepoint, 𝑡> , the POLYMOD 
matrices and the commuter data combine to produce contact matrices 𝚷(𝑡>) are given in 
Appendix 1. Figure 2 shows a heat map of the elements of 𝚷(𝑡B) as contact intensities on the 
absolute and log-scales. The strata are organised within regions, giving the matrix the 
appearance of an array of sub-matrix blocks within which the POLYMOD patterns of contact 
are repeated. The blocks on the diagonal give rates of within-region contact and therefore 
show much higher contact rates. 
 
Figure 2: Heat maps for the contact matrices used in the MR model (with regional density dependence) based on 
contact and log-contact rates respectively. The matrices show a strong block diagonal structure with red areas 
indicating higher rates of contact. The blocks are ordered such that contacts involving residents of London are in the 
top row and in the first column, with the ordering of London, West Midlands, North and, in the final row and 
column, the South. Within blocks, age is increasing top-to-bottom and left-to-right. Red squares indicate interactions 
of high frequency, white squares interactions of zero frequency. Reproduced from Birrell et al.28 
The MR model only has one system of dynamic equations of the type in Equation (8) 
of Appendix 1, removing the flexibility of having region-specific values for 𝑅0 and the initial 
seeding of infectives, 𝐼0. However, there are a number of modelling considerations to be 
made when using the MR model, considerations that are not relevant to the PR modelling 
approach. 
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Density Dependence: In a single-region model, the POLYMOD-based contact matrices give 
the relative frequency of contact between pairs of individuals of the different age groups. 
When these matrices are inserted into the block diagonal of the MR contact matrix (Figure 2), 
an assumption of frequency-dependent contact is made. This implies that individuals are 
equally likely to have contact with any other individual in the region irrespective of the 
region in which they live. Therefore, individuals that live in regions with a higher population 
will make proportionately more contacts. This may not seem to be a reasonable assumption, 
as the total population of a region does not necessarily indicate a high population density. 
The alternative considered here, are density-dependent contacts. In this case, the likelihood of 
a contact is scaled down by the population size, either of the regional population or of the 
strata (region and age) population. Both types of density dependence are considered. 
 
Initial Seeding of Infectives: At the beginning of an epidemic, the transmission process is 
kick-started by a number of initial infectives. The POLYMOD-based contact matrices used 
for a single region model (and in the PR model) will lead to rapid convergence towards a 
stable pattern of infection. In other words, for most reasonable choices of initial seeding, it 
takes only a short time for this seeding to be ‘forgotten’ by the transmission dynamics. 
This is not the case in the MR model, with its block-structured matrix. Infection 
spreads very slowly between the regions and so the initial seeding is not quickly forgotten. 
Epidemics seeded with infectives in different regions can lead to very different outcomes. 
Therefore, while the choice of the seeding in the PR model is not important, it is a significant 
modelling choice for the MR approach. Therefore, a number of different seedings are 
considered: the single-region equilibrium distribution (i.e. the stable pattern of infection 
observed in the PR model); the initial empirical age and region specific distribution of the 
initial confirmed cases; a hybrid approach using a within-region equilibrium distribution 
scaled by the empirical distribution of the initial confirmed cases over regions. 
 
Commuting-at-Random: Each model makes the assumption of homogeneous mixing within 
each stratum. This means that all individuals within a population stratum are as likely to 
acquire or spread infection as any other individual of the same infection status. In the MR 
model, where infection is transmitted between regions through the routine movements of 
commuters, this assumption of homogeneity implies that on any day each individual is 
equally likely to commute. This is an unrealistic representation, however, as it is likely to be 
only a subset of people commuting on a regular basis, and a (larger) subset who stay within 
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their home region. To account for this, adult age groups in each region are further sub-
divided into commuters and non-commuters, so that the commuters are a fixed group of 
people who move each day. This results in the effects of commuting upon transmission being 
more transient, as there is a smaller, more rapidly exhaustible, supply of susceptible 
individuals available to transfer infection from one region to another. 
The downside to this further level of stratification is that it places an increased computational 
burden on the model, greatly slowing down the estimation process. 
3.3 Data 
During the 2009 pandemic, HPA provided A/H1N1pdm incidence estimates for each of the 
then ten Strategic Health Authorities (SHAs) across England. Two of the SHAs, Greater 
London and the West Midlands, were believed to have experienced a significant, pre-
summer, wave of infection. Ideally we would adopt the same geographical partition. 
However, the volume of data available from each of the SHAs is insufficient to do so. A 
reasonable compromise solution is to divide the country into four spatial units: London, West 
Midlands (the two regions that had significant first waves of infection), North and South. The 
North region comprises four SHAs: North East, North West, Yorkshire and Humberside and 
East Midlands. The South region comprises four SHAs: East of England, South Central, 
South East Coast and South West. 
The age categorisation favoured by HPA, now PHE, is to break up the population into 
the age groups: < 1 years, 1−4 years, 5−14 years, 15-24 years, 25−44 years, 45−64 years, ≥ 
65 years. For the rest of this section, 𝑎 will denote a general population stratum, whether 
defined by age alone, or by both region and age. 
Section 3.3.1 itemises the pandemic data streams that the real-time modelling 
framework is set-up to work with, detailing, where applicable, how these data were used in 
modelling the 2009 pandemic and discussing how the various surveillance schemes have 
evolved over the intervening period. Section 3.3.2 introduces some statistical technical 
details, showing how these data streams link into the SEIR transmission model, covering the 
distributional assumptions that are required to allow formal statistical inference to be made. 
3.3.1 Pandemic Data 
GP consultation data PHE carry out syndromic surveillance to monitor influenza activity in 
the population by routinely collecting data on individuals presenting ILI at GPs. In 2009 such 
data were provided from two sources
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Royal College of General Practitioners (RCGP), a sentinel GP network covering a weekly 
population of approximately 900,000.30 The second source was the HPA/QSurveillance 
national surveillance system which covers a much larger population of ≈23 million people.31 
ILI data from both schemes were available stratified by both age group and SHA. In the end, 
daily ILI reports from the QSurveillance system were used to guide the public health 
response to the pandemic.31 
The GP data are reported counts of consultations for non-pandemic specific 
symptoms and include cases not infected with the pandemic pathogen. Therefore information 
is required on the proportion of the reported counts that are truly of interest when tracking the 
levels of transmission of the pandemic infection. RCGP augment their primary care 
surveillance with virological monitoring.32 This monitoring involves taking respiratory swabs 
from a subset (chosen at random) of patients consulting for ILI at participating GPs. A 
polymerase chain reaction (PCR) assay is then employed to test the swabs for the presence of 
influenza strains as well as other respiratory virus infections. Similar data are obtained and 
made available by PHEs Regional Microbiology Network (RMN), covering an additional 
400,000 patients in England.33 A complete account of the virological monitoring undertaken 
by the two schemes through 2009 can be found elsewhere,34 but together they provide data on 
the positivity of the swabs taken by GPs together with the epidemiological information 
attached to each sample. To ensure high sensitivity of the testing process, swabs were only 
included in any analysis presented here if the time between symptom onset and the swab 
being taken was at most five days. Combining this swabbing information with the GP 
consultation data, the number of consultations that are actually directly due to the pandemic 
can be estimated. 
Since 2009, PHE has expanded its primary care surveillance portfolio, now 
additionally working with The Phoenix Partnership to access anonymous GP records through 
their SystmOne computer system.35 These data could either be combined with the 
QSurveillance data or could provide an additional sample of data used for model validation. 
When infection becomes widespread, the National Pandemic Flu Service (NPFS) will be 
activated. The NPFS is an internet and telephone service designed to expedite the 
administration of antiviral drugs, alleviating the burden placed upon GP surgeries. In 2009 
this service launched and, after a short bedding-in period, was observed to be subject to the 
same trends as the GP-based data. Those using the service were also swabbed, to understand 
the underlying pandemic incidence. Due to an anticipated fall in the consultation numbers 
that would arise as a result of a NPFS launch, these data could easily be added (if the degree 
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of overlap between the two datasets is understood) or used to replace the GP consultation 
data to build a picture of the numbers accessing primary care services for ILI. 
 
Virologically confirmed cases Management strategies over the initial stages of the 2009 
pandemic were primarily concerned with the containment of the spread of the epidemic, prior 
to moving into a treatment phase. The initial containment phase was a period of enhanced 
surveillance during which contacts of known infected individuals were traced and laboratory 
confirmations of the infection were obtained whenever possible. This work resulted in the 
generation of the FF100 and the FluZone databases.34 Routine laboratory confirmations were 
discontinued on 25th June, but we use here the data only up to 19th June to allow for the 
gradual cessation in the collection of this type of data. In practice, any real-time modelling is 
likely not to start within the first five weeks from the start of the outbreak, due to the 
anticipated difficulty in detecting any signal from the epidemic data at such early stages. 
Instead it is anticipated that the information on confirmed cases in this period will inform the 
model construction and provide some prior information (see Sections 3.4.1-2) for various 
model parameters. In the analysis of the 2009 pandemic data, these data contributed to the 
analysis in the same way it is proposed (see below and Section 3.3.2) hospitalisation data will 
in future pandemics.  
 
Hospitalisation data – UK Severe Influenza Surveillance System (USISS) Prior to the 2009 
pandemic there was a gap in the surveillance of severe respiratory infections in the UK with 
regard to hospitalised cases of influenza. During the pandemic a web-based hospital reporting 
system was established to meet this need. The data were available relatively late in the 
pandemic and, even now, the biases and weaknesses of the data derived from this reporting 
system are not well understood. This motivated the development of a more robust, well-tested 
surveillance scheme for the reporting and handling of such important data. As a result, USISS 
was initiated during the 2010/11 influenza season, becoming routine for each subsequent 
season.36 Data collected during influenza seasons prior to any pandemic outbreak are 
anticipated to provide baseline information that may prove useful in identifying a pandemic 
‘signal’. 
Outside of a pandemic USISS is a two-stream surveillance system. All National 
Healthcare Service (NHS) hospital trusts carry out mandatory weekly reporting of admissions 
of severe influenza cases (i.e. admitted to a high dependency unit (HDU) or an intensive care 
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unit (ICU) together with laboratory confirmation of infection). USISS also provides sentinel 
influenza surveillance, through an annually selected random sample of trusts, where testing 
for the presence of influenza in all patients presenting ILI is mandatory and results are 
reported together with an array of epidemiological information. In the event of a pandemic 
being declared, all trusts will switch to this sentinel level of reporting. 
In a pandemic, therefore, USISS should provide a time series of reported cases that 
have two distinct advantages over the GP consultation data: 
• They are counts of laboratory confirmed cases, so there is no contamination from 
non-pandemic ILI. 
• The proportion of cases that are reported to USISS should be less volatile over time as 
it is a function of the severity of the virus and access to hospital services. 
However, hospital resources are finite and, in a rapidly developing pandemic, may quickly 
become exhausted and patients may well be turned away where previously they would have 
been hospitalised. In such a case, the proportion of cases that are hospitalized will decrease as 
a function of the increasing incidence. This decrease may be difficult to characterise, 
potentially limiting the period of time for which the hospitalisation data can be reliably 
informative. 
 
Serological Data Serological data are the only surveillance data source informing directly the 
transmission component of the real-time modelling framework. As the prevalence of 
immunity-conferring antibodies increases, the number of susceptibles decreases. In modelling 
the 2009 pandemic, the inclusion of serological data has been shown to be crucial to the 
reconstruction of the underlying epidemic curve.15 
Initially, the serological data used in the analysis of the 2009 data came from the 
HPA’s annual collection of residual blood serum samples submitted to microbiological 
laboratories for the purpose of carrying out cross-sectional antibody prevalence studies.37 
Later in the pandemic, it became clear that a more rapid, more representative approach to the 
collection of serum samples was required. Chemical pathology laboratories were therefore 
approached at hospitals in each of the RMN regions. This ensured a regular supply of age-
stratified serum samples, obtained in a timely fashion with good geographical coverage.38 In 
all samples, a haemagglutin-inhibiting antibody titer of 32 was assumed to be sufficient to 
indicate protection against A/H1N1pdm influenza.39-41 It is further assumed that there is a 
two-week delay between infection and seroconversion. Each sample was, therefore, treated to 
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be representative of the level of cumulative infection among the population 14 days prior to 
the sampling date. Testing also took place of some residual sera samples collected in 2008 to 
provide age-specific estimates of baseline antibody prevalence. 
Currently, ahead of each winter influenza season, researchers at PHE carry out 
stratified sampling from the population to select potential participants for a telephone survey 
regarding the public’s attitudes towards influenza vaccination.36 At the end of the survey, 
respondents are asked if they would be willing to submit a blood serum sample. Those that 
agree to take part will submit two samples, one at the start of the season and one at the end of 
the season. In the event of a pandemic outbreak that does not overlap with the winter flu 
season, the telephone surveys will be initiated as rapidly as possible. 
There is some uncertainty inherent in these data as to precisely what titre value will 
confer immunity. It is also possible that a different titre level may be required to indicate 
long-standing immunity to that which indicates recent infection. The real-time modelling 
system does allow for this potential difference in the titre thresholds but it does not yet 
account for any uncertainty in these values. 
 
Commuting Data Commuting data were extracted from the UK 2001 census.42 For 
individuals aged 16 years and older, these data are in the form of counts of the number of 
surveyed individuals in each age group and within each Government Office Regions (GOR) 
who, on the day of the census, travelled into another GOR and how many stayed within their 
home region. Data were then aggregated so that they conformed to the regional split chosen 
for modelling the 2009 pandemic - London, West Midlands, North and South. Denote the 
number of people in age-group 𝑎 who moved on the day of the census from region 𝑟 to 
region 𝑠 by 𝐶6,E∗ (𝑎), these numbers were standardised to give 𝐶6,E(𝑎) = 	 𝐶6,E∗ (𝑎)∑ 𝐶6,I∗ (𝑎)JIKB . 
Equation (13) in Appendix 1 illustrates how these data are combined with information from 
the UK component of the POLYMOD study to generate contact matrices suitable for use in 
the MR approach to handling spatially heterogeneous epidemics. 
Population totals stratified by age-group and GOR were also derived from UK Office 
for National Statistics (ONS) data, using the 2008 mid-year estimates.43 
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3.3.2 Distributional Assumptions 
Count Data GP consultation data, virological confirmations and hospital admissions are all 
examples of count data that the real-time modelling framework has been designed to 
accommodate. We assume these are realisations of either Poisson or Negative Binomial 
distributions. The expectations of these distributions have derivations that share some 
common features accounting for: 
• A delay from infection to the healthcare event being recorded. 
• The fact that these are a proportion of the symptomatic cases: those having a 
sufficiently severe illness or who make a particular healthcare choice. For data on 
hospitalisations this proportion is the case-hospitalisation or case-ICU risk, for GP 
consultations it is a time-evolving propensity for individuals to seek consultation in 
the presence of symptoms. 
Therefore, the expected number of daily reports of hospitalisations, denoted 𝜇MN(𝑡>) for day 𝑡>  within strata 𝑎 is linked to the daily number of new infections through an expression of the 
type: 
 𝔼P𝑋>,MR S = 𝜇MN(𝑡>) = 𝑝MR(𝑡>)U𝑞WRΔM(YZ[\])(𝑡>^W),>^BWK"  (1) 
where 𝑝MR(𝑡>) is the relevant case-severity risk, 𝑞WR is the probability that the time taken from 
infection to being reported in data as having been hospitalised spans 𝑙 time intervals, and ΔM(infec)(𝑡>) is the number of new infections at time 𝑡>  as found from Equation (11) in 
Appendix 1. 
For GP surveillance data the expected number of consultations arising from the 
pandemic, 𝜇Me(𝑡>), is calculated via a similar expression to Equation (1) 
 𝜇Me(𝑡>) = 𝑝Mf(𝑡>)U𝑞WfΔM(YZ[\])(𝑡>^W)>WK" . (2) 
Before this quantity can be related to data, however, there are a couple of extra 
considerations: 
• The non-pandemic consultations need to be added. Denote by 𝐵M(𝑡>) the expected 
values of these at time 𝑡> . 
• The within-week pattern of consultations has to be accounted for. Typically no data 
are reported on weekends and on bank holidays. This leads to a strong artefactual 
peak in the number of consultations each week on Mondays. 
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• Although the population coverage of PHE’s combined surveillance schemes in 
England is very high, it is still incomplete and this needs to be accounted for. The 
expected number of consultations needs to be scaled to allow for this incomplete 
coverage. Surveillance schemes will report daily coverage figures as a proportion of 
the total population in each strata, which we denote 𝐷M(𝑡>). 
The expected daily counts of consultations in a general strata 𝑎 on day 𝑡>  are 𝔼P𝑋>,Mf S such 
that 
 𝔼P𝑋>,Mf S = 𝐷M(𝑡>)𝜅j(kl) m𝜇Mf(𝑡>) + 𝐵M(𝑡>)o, (3) 
where 𝑑(𝑡𝑘) indicates the day of the week on which time 𝑡𝑘 falls and 𝜅j(kl) is the adjustment 
factor accounting for the within-week effects on reporting. These factors should be estimated 
subject to the constraint that ∏ 𝜅jrjKB = 1.  
In particular, the GP data are likely to be highly volatile due to the sensitivity of the 
population’s healthcare seeking behaviour to governmental advice and media reporting. If it 
is decided that, as in 2009, the most appropriate distribution for the consultation data is the 
negative binomial, then the real-time model will include dispersion parameters, 𝜂>,Mf , such 
that the variance is given by: VarP𝑋>,Mf S = w1 + 𝜂>,Mf x𝔼P𝑋>,Mf S. 
 
Sampling data Both the virological and serological data represent a number of positive 
readings in a sample of fixed size. 
Denote the virological data w𝑚>,Mz ,𝑊>,Mx, where 𝑚>,Mz  gives the number of swabs 
tested within five days of symptom onset and 𝑊>,M  is the number of those swabs that test 
positive for the presence of the pandemic pathogen. If we assume the PCR test has test 
sensitivity 𝑘sens and test specificity 𝑘spec then these data are binomially distributed with 
expected value 𝔼P𝑊>,MS = 𝑚>,Mz ~𝑘sens 𝜇Mf(𝑡>)𝜇Mf(𝑡>) + 𝐵M(𝑡>) + w1 − 𝑘specx 𝐵M(𝑡>)𝜇Mf(𝑡>) + 𝐵M(𝑡>). 
In all the analyses presented in this report, the virological testing procedure is assumed to be 
perfect with 𝑘sens = 𝑘spec = 1. 
 Similarly, we denote the number of blood sera samples that test positive for 
the presence of antibodies to be 𝑍>,M  amongst a total of 𝑚>,ME  samples. The expected number 
of positive samples is linked to the level of susceptibility in the population, 𝑆M(𝑡>), via: 
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𝔼P𝑍>,MS = 𝑚>,ME ~1 − 𝑆Mw𝑡>^>x𝑁M , 
where 𝑘0 is a time lag representing the number of time-steps required for the development of 
antibodies. In 2009 this was taken to correspond to 14 days. If pre-season sampling occurs 
prior to the chosen 𝑡B, for modelling purposes, these samples can be assumed to be 
informative about the population prevalence of antibodies on Day 1 of the outbreak and can 
be added as data at this time. 
3.4 Model Parameterisation 
Apart from parameters that describe some initial condition of the transmission model, 
parameters are permitted to vary over time, region and age. Appendix 2 details all the model 
parameters that can, in principle, be estimated within the real-time model framework. In 
reality, depending on the availability of relevant data, a subset of parameters is pragmatically 
chosen for estimation. Table 1 presents a list of the parameters estimated in the spatial 
analysis of the 2009 pandemic data, indicating whether each parameter varies across regions 
(denoted ‘Spatial’) or not (denoted ‘Global’). 
 
Table 1 Model parameters classified in the PR and MR models as either spatially varying or globally varying. 
Adapted from Birrell et al.28 
Parameter Description 
Model 
PR MR 𝜼 Dispersion parameters for GP consultation Spatial Spatial 𝑑 Average duration of infectious period Global Global 𝜙 Proportion of infections that lead to ILI symptoms Global Global 𝑚>, 𝑘 = 1, … ,5 Parameters of the contact matrices* Global Global 𝜓 Exponential growth rates Spatial Global 𝜐 Initial number of infectives, log-transformed Spatial Global 𝒑f Propensity of ILI patients to consult with their GP Spatial Spatial 𝒑R Propensity of ILI patients to receive case confirmation Spatial Spatial 𝜷 Regression parameters determining the rates of 
background ILI consultation 
Spatial Spatial 
𝜅j Day of the week effects on the reporting of GP 
consultations 
Global Global 
*These parameters act as multipliers to elements of the POLYMOD contact matrices29: 𝑚B is the factor by which contact 
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rates involving adults are down-weighted; 𝑚,𝑚 are reductions in contact rates among children aged 1-4 and 5-14 
respectively in the over-summer school holiday; and 𝑚,𝑚 are the corresponding reductions in contact rates for all other 
school holidays. 
 
 
Parameters 𝑑𝐼 and 𝜙 are deemed to be properties of the virus and therefore are treated 
to be constant over region, time and age. Parameters 𝜓𝑟 and 𝜈𝑟 describe initial conditions (see 
Appendix 2 for their interpretation) and therefore they have a region-specific value in the PR 
model and a global value for the MR model. As virological case confirmation data was used 
in the absence of consistent data on hospitalisations, the proportion of cases that received 
virological confirmation of their infection, is here set to be 𝒑R, is an observation model 
parameter, relevant only for the first 50 days of the epidemic, while this type of data were 
still being collected. Therefore, no temporal or age-specific variation is considered, although 
variation over regions is included on account of the very different levels of pandemic activity 
in each region over the early period. The specification of the parameter 𝜅𝑑 has already been 
discussed in the text following Equation (2). 
Parameter vector 𝒎 = (𝑚B, … ,𝑚) consists of mulitpliers to specified elements of 
the contact matrices. These parameters are used to measure the impact of school holidays on 
contacts among 1-4 and 5-14 year-olds, and to down-weight the contribution of all contacts 
involving at least one adult. 
Both parameter vectors 𝜼 and 𝒑𝑔 are properties of the reporting model for the GP 
consultations. Therefore, they both have a temporal changepoint at time 𝑡𝑘 = 83 days, the 
time of the NPFS launch. Additionally, 𝒑𝑔 differs across ages (different values for children 
and adults), as well as changing value at two points later in the epidemic to account for the 
gradual reversion in the public’s healthcare-seeking behaviour to pre-NPFS habits. Thus 𝜼 is 
an 8-dimensional parameter component and the 𝒑𝑔 parameters are 32-dimensional. 
The parameters describing the rates of non-pandemic ILI consultations, known as the 
background rates of consultation, have the most complex specification. Regional variation in 
these rates is specified through a log-linear regression model, allowing information on trends 
and age effects to be shared across regions. As the background rates of consultation are quite 
likely to be volatile over time, approximately fortnightly breakpoints are chosen, dividing the 
245 days under study into 17 distinct time segments.  
The modelling process begins with a first-phase of model choice within the PR modelling 
framework to specify the precise form of this regression. Letting 𝜏(𝑡𝑘) denote the fortnightly 
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interval into which time 𝑡>  falls, and explicitly denoting the strata by (𝑟, 𝑎), a saturated 
model for the consultation rates, 𝐵6,M(𝑡>), takes the form: 
 log m𝐵6,M(𝑡>)o = 𝜇 + 𝛼6 + 𝛽 + 𝛾M + 𝛿6 + 𝜖6M + 𝜍M + 𝜏6M; (4) 𝑟 ∈ {𝐿,𝑊,𝑁, 𝑆}, 𝜏 = 1, … , 𝑇§, 𝑎 = 1,… , 𝐴. 
 log m𝐵6,M(𝑡>)o = 𝜇∗ + 𝛼6∗ + 𝛽∗ + 𝛾M∗ + 𝛿6∗ + 𝜖6M∗ + 𝜍M∗ + 𝜏6M∗ ; (5) 𝑟 ∈ {𝐿,𝑊, 𝑁, 𝑆}; 	𝜏 = 𝑇§ + 1,… , 𝑇; 	𝑎 = 1,… , 𝐴. 
Parameters in (4) and (5) represent the main effects of region (𝑟), time period (𝜏) and age 
group (a) and their interactions; 𝑇𝑋 indicates the fortnightly time interval that concludes at the 
same time as the launch of the NPFS; and the regions {𝐿,𝑊,𝑁, 𝑆} correspond to London, 
West Midlands, North and South respectively. This specification implies that there are 
separate and non-interacting models for the periods pre- and post-NPFS launch. In a 
preliminary phase of modelling, regression terms from (4) and (5) are sequentially removed 
until there is an appreciable loss of fit to the data, to obtain simplified versions of the 
regression equations (see Section 4.1.4). 
3.5 Bayesian Inference 
In the Bayesian framework, statistical inference about an unknown parameter of interest, 𝜃, 
proceeds by combining a priori information about 𝜃 with data from a current study. The 
initial information on 𝜃 is expressed in terms of a probability distribution, 𝑝(𝜃), known as a 
prior. This distribution encapsulates all that is known (or not known) about the parameter 
(e.g. from expert opinion or historical data) before the current study is carried out. After 
carrying out the study and observing data 𝑦, the knowledge about parameter 𝜃 is updated to 
give a probability distribution, known as the posterior, 𝑝(𝜃|𝑦). This posterior distribution is 
found through Bayes’ formula 
 𝑝(𝜃|𝑦) ∝ 𝐿(𝑦; 𝜃)	𝑝(𝜃),	 (6) 
where 𝐿(𝑦; 𝜃) is the likelihood function, expressing the likelihood of observing data 𝑦 
conditional on the parameter taking value 𝜃. The likelihood for the spatial study and a 
summary of the chosen prior distributions for the parameters are given in Sections 3.5.1 and 
3.5.2. 
3.5.1 Likelihood 
Denoting 𝐾 to be the number of days over which we have epidemic data, and using bold to 
denote (possible) vector quantities, we write that the epidemic dataset is 𝒚B:® = (𝒚B,… , 𝒚®). 
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Each data vector 𝒚> contains components w𝒘>, 𝒙>f, 𝒙>R, 𝒛>x, consisting of the data types 
discussed in Section 3.3.2 with each data component containing strata-specific data reported 
at time 𝑡>. 
These data contribute to inference through the likelihood function. Conditional on all 
the model parameters, using 𝜽 to denote the list of parameters in Table 2, it is assumed that 
all observations can be considered independent. The likelihood is then expressed as: 
𝐿(𝒚B:®; 𝜽) = 	³³´𝐿(𝑤>,M|𝑚>,Mz , 𝜽)𝐿(𝑥>,Mf |𝜽)𝐿(𝑥>,MR |𝜽)𝐿(𝑧>,M|𝑚>,ME , 𝜽)¸J¹MKB®>KB . 
The terms inside the product correspond to the likelihood of virological swabbing data, GP 
consultation data, USISS hospitalisation data and serological data, all reported at time 𝑡>  and 
for each stratum 𝑎 (assuming here that this encompasses both age group and region). 
3.5.2 Priors 
Table 2 provides a summary list of model parameters and, in the spatial analysis, their 
assumed prior distributions, or fixed (known) values as applicable. In some rows of the table, 
dependence on region has been made explicit through the use of a subscript 𝑟. 		
Table 2 Prior information on model parameters. For each parameter grouping, the table specifies the prior 
distribution used, or, where the parameter is not to be estimated by the model, its fixed value. Adapted from Birrell 
et al.28 
Transmission model parameter Symbol Prior/Fixed Value 
Exponential growth rates 𝜓6	 ~Γ(6.3,57)	
Initial log-hazards of GP consultation  𝜐6	 ~𝑁(−19.15, 16.44)	
Mean Infectious Period  dI	 2	 + 	𝑍, 𝑍~Γ(518, 357)	
Mean Latent Period dL	 2	
Contact matrix parameters  mi	 	~𝑈[0, 1], ∀𝑖	
Initial proportion susceptible in age group a  𝜌M	 1 (< 1 years), 0.980 (1-4), 0.969 (5-14), 0.845 (15-24), 0.920 (25-44), 0.865 (45-64), 
0.762(65+) 
 	 	
Disease and Reporting model parameters 	 Prior/Fixed Value 
Mean (s.d.) of gamma distributed incubation 
times  
	 1.6(1.8)	
Proportion of infections symptomatic 𝜙	 ~𝛽(32.5, 18.5)	
Proportion of cases who consult a GP, 
varying by age, time and region [Note i 
=1,3,5,7 depending on time interval for 
𝑝6Mf (𝑡>)	 𝑝6Mf (𝑡>) = logw𝑝6,È/(1 − 𝑝6,È)x	
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child age classes and i = 2, 4, 6, 8 
otherwise.  𝑝6,È ∼ ⎩⎨
⎧ 𝑁(−0.187,0.166)	𝑖 = 1,2	(𝑡> ≤ 83)𝑁(0.426,0.929)				𝑖 = 3,4	(𝑡> ≤ 130)𝑁(−0.319,0.263)	𝑖 = 5,6	(𝑡> ≤ 178)𝑁(−0.284,0.264)	𝑖 = 7,8	(𝑡> > 178)	
Proportion of cases lab-confirmed 𝑝6R	 ~𝛽(1.03, 2.69)	
Mean (s.d.) of gamma distributed waiting 
time from symptoms to GP 
consultation 
	 2.0	(1.2)	
Mean (s.d.) of gamma distributed waiting 
time from symptoms to lab-confirmation 
	 6.6	(3.7)	
Mean (s.d.) of gamma distributed reporting 
delay of GP consultations  
	 0.5	(0.5)	
Reporting delay of Lab confirmations  	 0	
GP consultation data dispersion parameters 𝜂6,È	 ~Γ(0.01, 0.01)	
Regression parameters for the background 
consultation rates 
𝜷	 𝑁ÐB(𝟎,𝑽)	
Day of the week effects on the reporting of 
ILI cases, log-transformed  
log 𝜅j	 𝑁Ð(𝟎,𝑽Ó)	
 
The justifications for the majority of the choices in the table have been given 
elsewhere15 and Section 3.4 outlines which parameter components have been considered for 
the additional spatial variation. Where regional variation exists, parameters are identically 
distributed in each region. 
In short, parameters that are hard to estimate from this type of model and surveillance 
data, such as 𝑑𝐼 and 𝜙, have informative prior distributions based on historical studies and 
analyses of early epidemic data15; the prior for 𝒑𝑔 uses information from FluSurvey;44 the 
priors on the parameters 𝜓𝑟 and 𝜈𝑟 are given prior distributions that can be considered to be 
relatively uninformative, with the prior for the components of 𝜼 being particularly diffuse. 
The bottom two rows of the table are for parameters used to calculate the background 
consultation rates and the day of the week effects. These are given zero-mean multivariate 
normal distributions with covariance matrices 𝑽 and 𝑽Ó . The covariance matrices are 
designed so that the background quantities 𝐵6,M(𝑡>) and 𝜅j, 𝑑 = 1,… ,7, are uncorrelated and 
identically distributed wherever possible. 
3.6 Monte Carlo methods 
Typically, the posterior distribution of Equation (6) is only known up to a constant of 
proportionality and, as a result, is seldom possible to derive analytically, particularly so when 
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working with a model as complex as that of Figure 1. However, it is possible to obtain a 
sample from such a distribution. The class of methods used to produce such a sample are 
called Monte Carlo methods and two of the most common methods are discussed below. 
3.6.1 Markov Chain Monte Carlo (MCMC) 
MCMC, a widespread and popular algorithm for Bayesian computation, is used to derive 
estimates of the posterior distribution of the model parameters in the spatial analysis of 2009 
pandemic data. More detailed introductions to MCMC can be found elsewhere.21 However, in 
short, MCMC techniques are used when it is necessary to sample from a distribution where 
this sampling cannot be done directly. In any complex modelling scenario, the posterior 
distribution in Equation (6) represents such a distribution. MCMC works by generating a 
sequence of values, known as a Markov chain. If allowed to run for long time, this chain will 
eventually constitute a dependent sample from the desired distribution. Typically, one would 
run a small number of such chains (say, 2-5), starting each chain at dispersed values: the 
chains run for a burn-in period until samples derived from each are statistically similar. At 
this point it can be said that the chains have converged and then the chains run for a sufficient 
length of time to derive a sample of the desired quality. This can often require many 
iterations of the chain (in applications of dimension comparable to the dimension of the 
parameter vector in our example, often 104 − 106 iterations may be required) and can often be 
a time-consuming process as a result. 
To see how to generate a sample from a posterior distribution, some technical detail is 
required. Formally suppose that, at time 𝑡>  we are trying to derive a sample from the 
posterior 𝑝(𝜽|𝒚B:>) where 𝒚B:>  denotes all the data observed up to the present time. Suppose 
the parameter value at the 𝑛th iteration of the chain is 𝜽𝑛. From a carefully chosen probability 
distribution known as the proposal distribution, a new state for the chain is proposed, 𝜽∗~𝑞𝑘(· |𝜽𝑛). This value is then accepted as the next state of the chain with probability 
 minÖ1, 𝑝(𝜽∗|𝒚B:>)𝑞𝑘(𝜽𝑛|𝜽∗)𝑝(𝜽𝒏|𝒚B:>)𝑞𝑘(𝜽∗|𝜽𝑛)Ø .	 (7) 
If the proposed parameter value is not accepted then the chain stays where it is and 𝜽ÙÚB =𝜽Ù. 
The performance of a MCMC algorithm crucially rests on the choice of the proposal 
distributions 𝑞𝑘(· | ·). However, regardless of this choice, the algorithm remains highly linear, 
with minimal scope for taking advantage of the benefits offered by parallel computing. 
Therefore, this algorithm will struggle to reap any of the benefits of cluster computing. More 
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importantly, in an iteration of the algorithm, the suitability of proposed values is evaluated 
using knowledge of the full data likelihood (from time 𝑡0 to time 𝑡𝑘). This will require the 
evaluation of the system of equations in (8) in Appendix 1 and of Equations (1) and (2). 
When repeated 105 or (orders of magnitude) more times, this can compromise the capacity 
for timely, real-time inference. 
This motivates a more readily parallelisable algorithm, and one that is sequential in 
nature, demanding only the evaluation of the likelihood of the incoming batch of data, rather 
than the full data history. 
3.6.2 Sequential Monte Carlo (SMC) 
In general terms, SMC provides a prescription to sample from a target probability 
distribution, denoted π(·) by sequentially moving through a number of, say 𝐿, intermediate 
distributions 𝜋0(·), . . . , 𝜋𝐿(·) 	= 	𝜋(·). By setting 𝐾 = 𝐿 and 𝜋𝐿(·) 	= 	𝑝(· |𝒚B:Ü) it can be seen 
how this algorithm may lend itself to the problem of online inference. At the 𝑘th stage of the 
sequence of target distributions, a weighted sample of size 𝑛> from 𝑝(· |𝒚B:>) is obtained, 
denoted: 
 
 Ým𝜔>(B), 𝜽>(B)o,… , m𝜔>(Ùl), 𝜽>(Ùl)oß. 
Here, the weight 𝜔>(à) attached to a parameter value 𝜽>(à), known in this context as a particle, 
indicates the relative importance of the 𝑗th particle to the sample (known as the particle set). 
This means that if we have a function of the parameter, such as the epidemic trajectory, 
which we denote 𝑓(𝜽), then we would estimate it by its weighted mean 1𝑛>U𝜔>(à)𝑓m𝜽>(à)oÙlWKB . 
The basic idea is that the SMC algorithm proceeds by, upon observing a (𝑘 + 1)th batch of 
data, reweighting the sample according to the likelihood of the new data. This reweighted 
sample is theoretically representative of the next target distribution 𝜋>ÚB(·) = 𝑝(· |𝒚B:(>ÚB)) . 
Therefore, we can base inferences at time 𝑡>ÚB on the previous sample of parameter values 
and the new set of weights, which only require the likelihood of the new data to be calculated. 
This represents a significantly reduced computational burden, and as the reweighting for each 
of the particles can be calculated in parallel, it is a highly parallelisable computation too. 
Unfortunately, such a process swiftly suffers from a phenomenon called particle 
degeneracy. This happens gradually over time as the particle weights scale in such a way that 
only a very small handful of particles have non-negligible weight. When this degeneracy 
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occurs, although the weighted sample is of size 𝑛𝑘, the low weight attached to the majority 
effectively removes them from the sample and estimation and projections are made based on 
only a handful of particles and are therefore subject to significant error. 
To prevent this degeneracy, the sample requires some rejuvenation.45 The first step of 
this rejuvenation involves the removal of all those particles of too-low weight. This is done 
through a process of resampling. Here, a new sample is drawn from the old set of particles 
according to their weights. The consequence of doing this is that the sample is composed of 
multiple copies of a much smaller number of identical particles. It is therefore necessary to 
jitter this sample somehow. To do this, short MCMC implementations are run for each 
particle, using the current value of the particle as the starting state for the chain. 
The SMC algorithm: 
A brief overview of this algorithm is below, based on the resample-move algorithm.46 
1. Set 𝑘 = 0.	At time 𝑡", draw a sample Ý𝜽"(B), . . . , 𝜽"(Ù)ß from the prior distribution, 𝜋0(𝜽), set the weights 𝜔"(à) = 1/𝑛0 for all 𝑗. 
2. Set 𝑘 = 𝑘 + 1. Observe a new batch of data 𝒚𝑘. The particles are reweighted according 
to the likelihood of the incoming data 𝜔ã>(à) ∝ 𝜔>^B(à) 𝐿 m𝒚>; 𝜽>^B(à) o. 
3. Has the particle set become degenerate? If not, set 𝜽>(à) = 𝜽>^B(à) , 𝜔>(à) = 𝜔ã>(à), 𝑛> =𝑛>^B	and return to step (2). 
4. Resample Choose 𝑛𝑘 and sample Ý𝜽ä>(B), … , 𝜽ä>(Ùl)ß from the set of particles Ý𝜽>^B(B) , … , 𝜽>^B(Ùlåæ)ß with probabilities proportional to Ý𝜔ã>(B), … ,𝜔ã>(Ùlåæ)ß. Re-set 𝜔>(à) =1/𝑛>. 
5. Move For all 𝑗, move 𝜽ä>(à) to 𝜽>(à) via a short MCMC chain. If 𝑘	 < 	𝐾 return to step 2, 
otherwise end. 
 
Despite the presence of the short MCMC runs in step 5, this still presents a significant 
improvement over the plain MCMC algorithm because: 
• The computationally intensive steps of the algorithm (steps 2 and 5) both allow for 
calculations on each particle to be made in parallel. 
• At most times the particle set will not be degenerate and hence only the likelihood of 
the new data needs to be calculated to reweight the sample. 
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• Each of the many parallel MCMC chains can be assumed to start from a point that is 
sampled from the target distribution. There is therefore no need to allow the chain 
time to reach convergence and only very low numbers of iterations will be required. 
• Before the MCMC phase starts, we already have an estimated sample from the target 
distribution by using the weighted sample achieved in step 2. This estimate can be 
used to construct good proposal distributions for the MCMC, improving its efficiency. 
A number of algorithmic tweaks have been required to make the algorithm robust to the 
vagaries of epidemic data and characteristics of the real-time model. The technical detail 
involved has been presented elsewhere and only a brief overview is given here.47 
 
For how long should the MCMC run? The MCMC chains should be run for long enough to 
have a rich sample of parameter values, but for no longer than is strictly necessary to 
maintain real-time efficiency. At the start of the MCMC phase, there may be many particles 
with the same parameter value. These can be defined to be a cluster. The MCMC should be 
run for long enough so particles from different clusters have fully intermingled and the 
original clusters are no longer identifiable. 
To measure formally the dispersal of the particles, the intra-class correlation 
coefficient (ICC) is used.48 This measures the clustering in the value of a summary quantity 
calculated for each particle. The chosen summary was the projected epidemic “attack rate” 
(the total cumulative incidence measured as a proportion of the total population).47 At the 
start of the MCMC phase, the ICC = 1. As the iterations progress this value will gradually fall 
and the MCMC iterations will stop once the ICC falls below a pre-defined limit. It has been 
shown elsewhere that values in the range 0.1-0.2 should be adequate.47 
 
Choosing good MCMC proposals Expression (7) gives the acceptance probability for a 
proposed value for the next state of the chain. Within SMC, it is sought to diversify rapidly 
the set of particles, without running the chain for too long. To do this, we want to propose 
values for 𝜽∗ that are not too close to the current values, and that are likely to be accepted. By 
setting 𝑞𝑘(𝜽|𝜽>(Ù)) 	= 	𝑝𝑘(𝜽|𝒚B:>), the acceptance ratio would always be 1 (so the proposal 
will definitely be accepted). This has the added advantage that the proposal is independent of 
the current state of the chain, so immediately the set of particles would be intermingled. 
Unfortunately, we cannot sample directly from 𝑝𝑘(𝜽|𝒚B:>) so easily. But, after step 2 
of the algorithm, we have a weighted sample that should approximate a sample from this 
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distribution. Therefore, by choosing 𝑞𝑘(· | ·) to be a multivariate normal distribution centred 
on the weighted mean and weighted covariance of the particle set calculated at the end of step 
2, we have a distribution that approximates the target density and should ensure reasonable 
rates of acceptance, while rapidly replenishing the particle set. This works well, provided the 
particle set at the end of step 2 has not become impoverished to the degree it cannot provide a 
reasonable approximation to the target distribution.47 
 
When to rejuvenate? When are the particles degenerate? The standard approach is to 
rejuvenate the particle set when the effective sample size (ESS) falls below a specific level.49 
The ESS is a measure of the number of independent, equally weighted observations from the 
target distribution that are as informative as the weighted particle set. At the end of step 2 of 
the algorithm, the ESS is calculated as: 
ESS mÝ𝜔ã>(B), … , 𝜔ã>(Ùlåæ)ßo = m∑ 𝜔ã>(W)ÙlåæWKB o∑ m𝜔ã>(à)oÙlåæàKB  
Values of the ESS that are close to 𝑛>^B indicate a sample that contains plenty of information 
about our posterior distribution. A typical level above which the ESS is deemed to be 
acceptable (and there is no need to rejuvenate the sample) is if ESS ≥ 𝑛>^B/2. 
In some of the examples, such as those considered in Section 4.2, there are times 
when the addition of the next batch of data in the sequence can lead to a sudden drop in the 
ESS to very low values. In such cases the MCMC algorithms have too much work to do to 
adjust the sample and timely inference would not be possible. Therefore, to limit the 
depletion in the ESS, we introduce rejuvenation steps at intermediate times, between 𝑡𝑘 and 𝑡>ÚB, by adding in the data fractionally. If we add a fraction of the data, 𝛼, such that 0 < 𝛼 ≤1, then a value 𝛼0 can be identified such that the ESS only falls to approximately 𝑛𝑘/2. The 
next batch of data to arrive is either the remaining portion of the time 𝑡>ÚB data, or a further 
portion of it, sufficient to once again bring the ESS down to the threshold value. This is the 
‘real-time’ algorithm presented in the technical publication reporting this work.47 
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4. Results 
4.1. Spatial modelling 
This section presents the statistical results obtained when applying the PR and MR modelling 
frameworks to reconstruct the 2009 A/H1N1pdm outbreak in England and, in particular, to 
characterise the impact of inter-region transmission. As discussed in Section 3.2.2, there are a 
number of competing hypotheses regarding the precise formulation of the MR model and 
initially we shall present results that assumed the ‘best fitting’ MR model, before discussing 
in Section 4.1.5 the exact composition of this model. 
4.1.1 Reconstructing the epidemic 
Both of the PR and MR models are sufficiently flexible to be able to reproduce the two 
epidemic waves of the 2009 pandemic. The estimated incidence curves are reproduced in 
Figure 3. The estimated epidemic in the North is consistent across both models. London and 
the West Midlands are characterised by bigger first waves of infection (and subsequently 
smaller second waves) under the PR model, the opposite being true for the South. This is 
apparent from the peaks in Figure 3 and the given population-level attack rates in Table 3 
(age-specific attack rates can be found in Appendix 5). Peak timings in both waves of 
infection are the same under both modelling approaches and coincide with the start of school 
holidays, with the exception of the second wave in the West Midlands. Here, a sufficient 
supply of susceptible individuals remains in the population after the holiday  
to allow transmission to increase once more (albeit briefly). This may well, however, be a 
phenomenon of different school term dates in this region to those that predominate elsewhere 
in the country. 
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Figure 3 Estimated weekly number of new A/H1N1pdm infections by region (by row) under the PR model (left 
column) and the MR model (right column). Solid black lines represent incidence summed over age groups with an 
associated 95% CrI (dashed lines). Figure reproduced from earlier publication.28 
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Table 3 Posterior median and 95% CrIs for cumulative incidence of infection, number of cases (both given in 
thousands) and attack rates, by region and by pandemic wave (May-August or September-December). Adapted from 
Birrell et al.28 
 
4.1.2 Estimated epidemic characteristics 
Table 4 presents estimates of some key transmission parameters under both models. There is 
a pleasing consistency across the modelling approaches in the parameter estimates. For 
example, estimates for the (initial) reproductive number (𝑅"init), derived from the exponential 
growth rates, are centred on 1.8, with the region-specific estimates of the PR model being 
tightly distributed around this value. This is in broad agreement with other estimates for 𝑅" 
obtained from a review of 2009 pandemic transmission parameter,50 and a slight increase on 
what had been estimated for the single region version of the model.15 In a similar (single-
region) modelling study, much higher estimates for the 𝑅" associated with the A/H1N1pdm 
virus have been derived, though this was over the course of a later third wave of pandemic 
infection occurring in the winter season 2010-11.51 Similarly, the estimates for the other 
transmission parameters are robust to the model specification (note the overlapping nature of 
Parallel-region model 
May-August London West Midlands North South 
Infections 988 (958, 1124) 525 (456, 600) 1058 (839, 1316) 692 (554, 854) 
Cases 152 (123, 184) 80 (65, 98) 161 (121, 215) 105 (80, 139) 
Attack rate (%) 13.2 (11.4, 14.9) 9.8 (8.5, 11.2) 5.6 (4.4, 6.9) 3.6 (2.9, 4.5) 
September-December 
Infections 764 (641, 901) 571 (483, 656) 3671 (3379, 3987) 3750 (3508, 4021) 
Cases 117 (91, 153) 87 (64, 115) 563 (462. 689) 576 (471, 697) 
Attack rate (%) 10.1 (8.5, 11.9) 10.6 (9.0, 12.2) 19.3 (17.8, 21.0) 19.6 (18.3, 21.0) 
Meta-region model 
May-August London West Midlands North South 
Infections 751 (674, 832) 669 (621, 718) 886 (792, 986) 1150 (1036, 1270) 
Cases 85 (74, 98) 76 (66, 88) 100 (87,117) 130 (113, 151) 
Attack rate (%) 9.9 (8.9,11.0) 12.4 (11.5,13.3) 4.7 (4.2,5.2) 6.0 (5.4, 6.6) 
September-December 
Infections 1228 (1129, 1331) 477 (405, 559) 3923 (3721, 4129) 3450 (3256, 3658) 
Cases 140 (114, 172) 54 (42, 69) 447 (377, 532) 393 (329, 472) 
Attack rate (%) 16.2 (14.9, 17.6) 8.9 (7.5, 10.4) 20.6 (19.6, 21.7) 18.0 (17.0, 19.1) 
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the CrIs in Table 4). In particular, parameter 𝑚B that gives the down-weighting applied to all 
contacts involving adults, is estimated consistently to be in the range 0.57-0.62. Estimates for 𝑚 indicate that the summer school holiday period reduced the rate of effective infectious 
contacts among the 5-14 year-old age group to below 3% of the school term-time figure. 
However, when averaged over all age groups, this represents a drop in 𝑅"init of between 43% 
(in London) to 50% (in the South). To compare, a Canadian study recorded a 28% drop in 
transmissibility during a similar school holiday period.52 The reduction in the effective 
contact rates in the other school holidays, as measured by parameters 𝑚 and 𝑚 were 
neither as well estimated (note the width of the credible interval attached to the estimates for 
parameter 𝑚) nor did they indicate a similar reduction in the contact rates, the shorter 
duration of these holidays evidently causing a milder disruption to routine contact patterns. 
Estimates for the proportion symptomatic, 𝜙, do appear to be rather low, although consistent 
across approaches and with an estimate of 11% based on a closely observed outbreak.53 
 
Table 4 Posterior median and 95% CrI for key parameters by modelling approach. Estimates of the reproductive 
number (R0) from the PR model are 1.79 (1.74, 1.83), 1.80 (1.76, 1.85), 1.82 (1.78, 1.87), 1.77 (1.73, 1.80) for London, 
West Midlands, North and South respectively. Adapted from Birrell et al.28 
Parameter PR model MR model 𝑅" - 1.81 (1.77, 1.84) 𝑑 3.47 (3.35, 3.59) 3.46 (3.34, 3.58) 𝜙 0.154 (0.126, 0.186) 0.114 (0.098, 0.134) 𝑚B 0.569 (0.536, 0.605) 0.618 (0.584, 0.651) 𝑚	 0.901 (0.610, 0.996) 0.666 (0.265, 0.740) 𝑚	 0.007 (0.000, 0.032) 0.006 (0.000, 0.032) 𝑚	 0.167 (0.008, 0.669) 0.214 (0.004, 0.909) 𝑚	 0.446 (0.341, 0.557) 0.411 (0.291, 0.528) 
 
4.1.3 Comparison between MR and PR modelling 
In Table 5, the posterior mean deviance is used to discriminate between different 
formulations of the MR model (to be discussed further in Section 4.1.5), comparing each 
formulation relative to the comparable PR model. If, in fitting these models, MCMC provides 
a sample of parameter values ´𝜽(B), … , 𝜽(Ù)¸, then the posterior mean deviance is defined to 
be 𝐷ë = −(2/𝑛)∑ logm𝐿ëw𝒚B:®; 𝜽(à)xoÙàKB , where 𝐿ë(∙	;	∙) indicates the likelihood under a 
specific model, 𝑚. It stands to reason, therefore, that lower values of 𝐷ë are preferred. The 
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discrepancy between the PR model and the best performing MR model is 57.89. Due to the 
regional variation permitted by the PR model in the estimation of 𝑅"init and 𝐼", the PR model 
has six more parameters than the MR model. This improvement in deviance for such a small 
number of parameters suggests that the PR represents a significantly better fit to the data. 
This compounds the practical benefit of the PR model being markedly faster to implement - it 
is more suited to parallel computation and the calculation of 𝑅"∗  in Equation (10) of Appendix 
1, requires the calculation of eigenvalues of (7 × 7) matrices rather than the (28 × 28) or (44 × 44) matrices required by the MR model. 
  
Table 5 Posterior mean (and standard deviation, s.d.) deviances for some candidate parameterisations of the MR 
model, expressed as a discrepancy from the deviance of the PR model. The smaller values of the posterior mean 
deviance represent models providing a better fit to the data. Adapted from Birrell et al.28 𝜶 Density type Seed type Commuting ∆𝑫(𝜽) (s.d) 
0.0 By strata nextgen random 3,890 (34.23) 
0.0 By strata nextgen fixed 4,376 (33.83) 
0.0 By strata empirical random 4,548 (31.53) 
0.0 By strata empirical fixed 4,949 (32.21) 
0.5 By strata nextgen random 3,025 (34.21) 
0.5 By strata nextgen fixed 2,241 (32.13) 
0.5 By strata empirical random 3,191 (36.65) 
0.5 By strata empirical fixed 2,269 (31.90) 
1.0 By strata nextgen random 2,770 (30.23) 
1.0 By strata nextgen fixed 2,466 (30.05) 
1.0 By strata empirical random 2,578 (29.43) 
1.0 By strata empirical fixed 2,359 (29.39) 
1.0 By region nextgen random 449.2 (27.60) 
1.0 By region nextgen fixed 437.9 (27.21) 
1.0 By region empirical random 170.1 (28.47) 
1.0 By region empirical fixed 166.4 (29.76) 
1.0 By region hybrid random 57.89 (27.20) 
PR model 0 
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4.1.4 Finding an optimal parameterisation 
Inferences drawn from either the PR or the MR modelling approach are found to be sensitive 
to the precise form of the regression for the background rates of GP consultation. Because of 
this, it was important to implement sub-models of Equations (4) and (5) in order to most 
appropriately characterise the changes in consultation behaviour over the pandemic period. 
Again, the posterior mean deviance was used to identify a most appropriate model. The real-
time PR model was repeatedly implemented with the higher order interactions systematically 
removed from equations (4) and (5) in the hope of finding simplified regression models 
without incurring any significant loss of fit to the data. Additionally, some age groups and 
regions were paired together, to cover gaps where data was too sparse to warrant the 
additional age/region effects. Under the PR model, the seemingly optimal choice for the 
regression model, and the one that has been used in the generation of all the results presented 
in this Section is: logw𝐵6,M(𝑡>)x = 𝜇 + 𝛼6 + 𝛽 + 𝛾M + 𝛿6 + 𝜖6M; 	𝑟 ∈ {𝐿,𝑊, 𝑆}; 	𝜏 = 1, …𝑇§; 𝑎 = 2,… , 𝐴	log m𝐵6,M(𝑡Ù)o = 𝜇∗ + 𝛼6∗ + 𝛽∗ + 𝛾M∗ + 𝜖6M∗ ; 	𝑟 ∈ {𝐿,𝑊, 𝑆}; 	𝜏 = 𝑇§ + 1,… , 𝑇; 𝑎 = 2,… , 𝐴.		
Here, the rates for the North and South have been equated 𝐵ð,M(𝑡>) = 𝐵ñ,M(𝑡>), an 
unsurprising finding given that there is sparse virological data in the North to accurately 
estimate the non-pandemic consultation rates here. Also, the rates in the two youngest age 
groups have been set to be equal (note the sum over the a index omits a=1), 𝐵6,B(𝑡>) =𝐵6,(𝑡>), again a not unreasonable finding given that the only the virological swabbing and 
not the QSurveillance GP datasets provide data with sufficient granularity to distinguish 
between the first two age groups (the < 1 and 1-4 year olds). 
When the same model refinement process was undertaken using the MR model, the 
same regression equations were again preferred. 
Having established the form of the background consultation rate regression, the next 
stage of model building in the MR approach was to consider the alternative model 
formulations of Section 3.2.2, governing how the model handles density dependence, random 
commuting and the choice of the initial seeding. Examination of the posterior mean deviances 
presented in Table 5 shows that density dependence is best accounted for by scaling entries of 
the contact matrices by the population of the region, not the population of the relevant strata, 
i.e. by replacing 𝑁6,M  and 𝑁z,M  in Appendix 1 Equation (13) with 𝑁6 and 𝑁z, the sum of the 
regional populations over age-groups. Furthermore, it was found that within-region 
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transmission that is density dependent (corresponding to the case 𝛼 = 1 in Equation (13) of 
Appendix 1) gave better model fit than either frequency dependent transmission (𝛼 = 0) or a 
mixture of the two (𝛼 = 0.5). 
MR model performance is highly sensitive to the choice of initial seeding of 
infectivity, with the hybrid seed performing most strongly. When the number of strata is 
expanded to partition between non-commuting and commuting adults, there was no 
consistent improvement in model performance (nor any particular worsening). However, the 
extra complexity and computation required to evaluate the model with the expanded number 
of strata indicates that the reduced stratification would be preferred in a real-time context. 
This suggests that the effects of inter-region transmission are either highly transient, 
sufficiently so that its effects are swallowed up by the choice of seeding, or the movement of 
individuals between regions is poorly characterised by the commuting data. The formulation 
of the contact matrices assumes that infected individuals move as freely as uninfected 
individuals and this may well be unrealistic. However, accounting for this would further 
reduce any difference in model performance between the two approaches, leading to no 
material adjustment of the conclusions. 
All results presented that quote the MR model will refer to the best-performing 
variant with 𝛼 = 1, density dependence governed by the regional population size, using the 
hybrid seed and assuming commuting at random. 
4.1.5 Goodness-of-fit 
Appendices C and D give goodness-of-fit plots for three of the data types (GP consultation 
data, virological positivity and serological) under the PR and MR models respectively. There 
is no apparent lack of fit under either model, with most data points lying within the 95% 
predictive intervals. There are a couple of instances where the model predicted seropositivity 
is too high (Greater London, ≥ 65) and others where it is too low (Greater London 5-14). It 
would seem that this arrives due to poor estimation of the initial proportion of susceptible 
individuals (this is a priori estimation, it was not carried out as part of the real-time model 
effort). Even in these cases, the PR model gives the better fit to these outlying data points, 
with fewer points missing their predictive intervals. Elsewhere, the performance of the PR 
model is evidently superior, in accordance with findings already presented. 
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4.2 Comparison of the real-time performance of the Monte Carlo methods 
The results of Section 4.1 were all obtained using MCMC. A posterior sample from the PR 
model could be derived in about 13-15 hours using MCMC, with some parallelisation of the 
likelihood. The MR approaches took considerably longer, particularly under the fixed 
commuter assumption when there were 44 population strata. At this point, the run-time 
stretches into days. Even at 13 hours, however, this is longer than a typical working day and 
eliminates the possibility of providing real-time analysis. Furthermore, it is not yet considered 
that in any future pandemic, there should be a sufficient wealth of data to allow a greater sub-
division of England, at least into the nine GORs, or that the improved quality of surveillance 
data might lead to an expansion in the number and type of parameters that can be estimated. 
Alternatively, the next pandemic to occur might be longer lasting, giving longer time series of 
data. All of these factors can greatly increase the level of computation required to draw the 
required statistical inference. It is not desirable that estimates are rendered obsolete by new 
data before they can be produced. 
This highlights the importance of developing a good statistical algorithm for 
analysing the data in a timely fashion. The algorithm has also to be able to be expressed in 
sufficient generality that it can be encoded within software for future use by an infectious 
disease epidemiologist whose knowledge of computational techniques in statistics may be 
minimal. As alluded to in Section 1, there is reason to believe that SMC algorithms may 
permit the iteration of analysis in a much more timely fashion. In this section, the efforts to 
tailor a suitable yet reasonably general SMC algorithm are discussed, testing the approach 
against simulated data, the generation of which is described in what follows. The central idea 
is that the data should be realistic, yet have features that are challenging to track, a reasonable 
“worst-case” scenario.  
4.2.1 Simulated data 
It was decided to copy many of the features of the 2009 pandemic. The simulated 
outbreak starts with an initial burst of infections in the spring, so that the epidemic is in full 
exponential growth by the time of an over-summer school holiday. The school holiday acts as 
a break on transmission, partitioning the outbreak into two distinct waves of infection. 
Although we only consider this one underlying epidemic, we consider two different data 
scenarios. In the first scenario, it is assumed that there is direct information on confirmed 
cases, such as might occur in the surveillance of severe disease (e.g. hospitalisation or ICU 
data from USISS). In the second scenario, ILI consultations, contaminated by non-pandemic 
53 
 
infections replace the confirmed case data. Both data streams are assumed to exist alongside 
serological data. In the second scenario it is necessary to have companion virological 
swabbing data to identify the degree of contamination in the ILI data. 
To ensure that the task of epidemic tracking is realistic, in the same vein as the NPFS 
introduction in 2009, it is assumed that there is a “shock” in the data provided by the 
surveillance schemes. Such a shock would be provided by a public health intervention 
designed to alleviate overcrowding in primary healthcare services or to reduce the demand on 
hospital beds. The net result of the intervention is that a much-reduced proportion of cases 
report their symptoms to the respective surveillance schemes, with the timing of the 
intervention, as in 2009, following shortly on from the over-summer closure of schools for 
the holiday period. 
To illustrate the size of the system shock that is being considered, the synthetic data to 
be used in the second scenario are presented in Figure 4. 
  
Figure 4 Top row: (A) Observed number of GP consultations; (B) Swab  positivity data with numbers representing 
the size of the weekly denominator. Bottom row: (C) serological data; (D) the pattern of background consultation 
rates for the GP consultation data aggregated over ages. The red arrows over figures (A) and (C) highlight the timing 
of some key, informative observations. 
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4.2.2 Scenario 1: A naïve algorithm 
Here we want to compare the relative performance of the SMC algorithm against what we 
consider to be a gold standard, the MCMC algorithm that was used to derive epidemic 
inference in earlier analysis of the 2009 data.15 
To attempt this, MCMC analyses are carried out after 50, 70, 83, 120, 164 and 245 
days of data have been observed. The SMC algorithm was then applied starting from the 
MCMC-derived posterior from 50 days, to see if, after the addition of 20 consecutive days, or 
batches, of data, the SMC and MCMC derived posteriors are statistically similar. This 
process was repeated to see if SMC could also bridge the gap between the MCMC analyses at 
days 70 and 83, days 83 and 120, days 120 and 164, and days 164 and 245. 
Initially, a fast, naive SMC algorithm was tried in application to the first data 
scenario, where we have contamination-free hospitalisation data. Here, the MCMC step 
embedded within the SMC algorithm would only last for one iteration, and rejuvenation of 
the particle set would only take place after the assimilation of whole batches of data (none of 
the fractional addition of data discussed in the ‘When to rejuvenate’ discussion in Section 
3.6.2. Figure 5 shows some of the results of doing this. In the scatter plots, the grey points 
show the starting MCMC-obtained distribution. Against this, left hand scatter plots are to be 
compared to the right hand scatter plots. In the right-hand side, all (non-grey) scattered points 
are of the same colour, because they are all of equal weight, equal importance. In the left-
hand column, the darker the point, the greater weight it carries. 
The immediate point to notice is that the SMC-obtained posteriors in the top and 
bottom panels would appear to be comparable to the MCMC-obtained posterior distributions, 
but the posterior distribution obtained by the naive SMC algorithm at time 𝑡> = 120 displays 
significant degeneracy. The algorithm has not tracked the movement of the posterior density 
over the interval from 83 days to 120 days. It is this sample impoverishment that makes the 
naïve SMC inefficient at such a time. 
Referring to the plots of the simulated data in Figure 4, the superimposed vertical red 
arrows identify points in time where there are particularly informative observations. 
Immediately after time 𝑡> = 83 there is a shock to the epidemic system as a public health 
intervention cuts the proportion of infections that are reported into data. At time 𝑡> = 110, 
there is a particularly large batch of serological data, data that is particularly informative. 
These two occurrences make it particularly hard for the naive algorithm to track the 
epidemic. Particularly, after the 𝑡> = 83 shock, a number of new parameters become active 
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(i.e. begin to have influence over the likelihood). As parameters first begin to move away 
from their prior density, it can cause severe depletion of the particle set. In comparison, the 
50 to 70 day and the 164 to 245 day intervals are relatively uneventful and much easier for 
the algorithm to track. 
It is this phenomenon that motivates a focus on the day 83 to day 120 interval moving 
forward, and also motivated the algorithmic adaptations discussed at the end of Section 3.6.2. 
We also consider the second data scenario, where we consider the syndromic GP counts, 
inclusive of non-pandemic noise and virological swabbing data. 
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Figure 5 Comparison of naive SMC-obtained posteriors and MCMC-obtained posteriors at 𝒕𝒌 = 𝟕𝟎 (A), 𝒕𝒌 = 𝟏𝟐𝟎 
(B) and 𝒕𝒌 = 𝟐𝟒𝟓 (C) days, via scatter plots for the parameters 𝝍 and 𝝊. 
4.2.3 Scenario 2: Heavy-duty SMC 
If the MCMC-derived posteriors are to be treated as a (albeit computationally costly) gold-
standard, a measure of similarity is needed between the SMC- and the MCMC-derived 
distributions, and for this we use Küllback-Leibler (KL) divergence.54 This is a statistic that 
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gives a measure of how different an estimate for a probability distribution is to its ‘true’ 
target. Here, we are presuming that it is the MCMC that represents the truth. 
Table 6 gives the KL statistics achieved when the full SMC algorithm was used over 
the day 83 to day 120 interval, breaking the interval down even further so we can look at KL 
discrepancies in the immediate aftermath of the shock at 𝑡> = 83 days. The table also shows 
three different levels of ICC threshold used as a stopping criterion for the MCMC phase. At 
each time, the ‘gold standard’ MCMC analysis was repeated numerous times and then 
referred back to a reference analysis. This was done to build up a distribution of KL statistics, 
so that the SMC analysis could be given a KL ‘target’, the upper 95 percentile of the KL 
statistics calculated on the sample of MCMC analyses. If the SMC analysis had a KL statistic 
that was lower than the target value, then it could be said to be indistinguishable from the 
MCMC analyses. At this point, we know that the SMC algorithm is responding adequately 
well. 
Table 6 Performance of the adapted SMC algorithm over the interval 83-120 days by ICC threshold. 
ICC threshold 0.5 0.2 0.1 
84 Days (KL target = 0.732) 2.92 2.87 2.83 
85 Days (KL target = 0.135) 3.05 3.00 2.98 
86 Days (KL target = 0.365) 3.28 3.24 3.25 
87 Days (KL target = 0.276) 2.54 2.45 2.42 
90 Days (KL target = 0.159) 1.80 0.353 0.0663 
100 Days (KL target = 0.135) 0.157 0.102 0.0890 
110 Days (KL target = 0.122) 0.159 0.0774 0.111 
120 Days (KL target = 0.119) 0.136 0.0435 0.0708 
 
From Table 6 it can be seen that from about day 87 onwards, the SMC algorithm (for 
the ICC thresholds 0.1 and 0.2) begins to regularly hit its KL target. The problem, therefore, 
lies in the days immediate preceding this point in time, where, not only are the KL statistics 
large, but the MCMC-component of the SMC algorithm was requiring vast numbers of 
iterations and becoming prohibitively time consuming. 
Addressing the speed issue first, it was found that one particular parameter was 
causing the slow convergence. As discussed elsewhere,47 it was found that, if proposals for 
the overdispersion for the negative binomial data 𝜼 were made separately to the rest of the 
parameter vector 𝜽 (which is updated together in one block), convergence could be achieved 
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much more rapidly. Figure 6 shows the improvement in the number of iterations required per 
day from over 400 per particle under the original SMC algorithm to 70 under the tailored 
version on day 89, with this improved performance evident for a number of days in the 
aftermath of day 83. Under both schemas, rejuvenations are required at the same times, but 
don’t require the same computational effort. Both versions of the algorithm perform similarly 
from around day 90-91 onwards. 
 
Figure 6 (LHS panel) Number of MH-steps required by the continuous-time SMC algorithm per rejuvenation against 
the timing of the rejuvenation for both the continuous-time algorithms (black and red correspond to with and 
without 𝜼 in the block updates) with the ICC threshold = 0.1 (solid line), 0.2 (dashed line) and 0.5 (dotted line). (RHS 
panel) Total number of MH-steps required by the continuous-time SMC algorithm per time interval with ICC 
threshold = 0.1 and with (grey bars) and without (magenta) 𝜼 in the block updates. 
This simple tailoring of the algorithm, only really necessary while a parameter is only 
weakly informed by the data and has an uninformative prior attached to it, evidently speeds 
up the algorithm, but it is necessary to show that this causes no degradation in terms of the 
inference that can be gathered. Table 7 repeats the exercise of Table 6, showing performance 
that is almost identical over the period 84-87 days (inclusive), the period over which there is 
a substantial speed up in the implementation of the algorithm. Thereafter, for the thresholds 
0.2 and 0.1 the performance is comparable to MCMC, with the exception of what appears to 
be an anomalous reading for the 0.1 thresholds at 90 days. 
Table 7 Performance of the tailored SMC algorithm over the interval 83-120 days by ICC threshold. 
ICC threshold 0.5 0.2   0.1 
84 Days (KL target = 0.732) 2.97 2.85 2.86 
85 Days (KL target = 0.135) 3.06 2.97 2.98 
86 Days (KL target = 0.365) 3.27 3.22 3.26 
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87 Days (KL target = 0.276) 2.51 2.48 2.44 
90 Days (KL target = 0.159) 2.10 0.0927 1.42 
100 Days (KL target = 0.135) 0.107 0.0835 0.0701 
110 Days (KL target = 0.122) 0.197 0.0373 0.0348 
120 Days (KL target = 0.119) 0.0999 0.0423 0.0551 
 
 
But the failure of the algorithm to hit the MCMC thresholds over the interval 85-87 
days (and 88, 89 days also, not shown) is a concern, and motivates an examination of 
scatterplots akin to those of Figure 5. In Figure 7 we look at the some scatterplots of the 
MCMC- and SMC-derived posterior distributions for two regression parameter components 
of the non-pandemic ILI consultations, 𝜷. The plots headed MCMC are comparable to the 
SMC-derived plots immediately to their left. What they show is that, most strikingly on the 
84 to 85 day and the 85 to 86 day steps, the MCMC algorithm isn’t capable of the same 
coverage of the space that the SMC algorithm achieves. This is a result of poor convergence 
of the MCMC algorithm. It gets stuck within a smaller range of values. It maybe that the 
MCMC algorithm needs many more iterations to properly sample the full range of values, but 
it is already at a considerable computational disadvantage (typical runs are of chains of length 
750,000 iterations). 
There is, therefore, a strong suggestion that the MCMC analysis, far from being a 
gold standard, is actually inferior to the SMC analysis. Where Table 7 seemingly shows the 
supposed inability of the SMC to provide a posterior sample that could be considered 
representative of the MCMC sample, this may actually be due to the weakness of the MCMC 
algorithm, and SMC is preferred. 
Returning to Figure 6, on the arrival of the data from day 84, each particle can be seen 
to require 220 iterations to accurately transition to a suitable posterior sample. When 
considered across 104 particles, this represents a number of evaluations of the full likelihood 
that are less than 4 × what would be required by the 750,000 iterations of the MCMC 
algorithm typically used to derive a sample. As multiple chains are typically required to 
correctly diagnose convergence and to provide a sample, then it can be seen that the SMC 
would only require only very modest benefits from parallelisation to be quicker to compute. 
When placed on a computing cluster, the SMC is considerably quicker to implement. The 
SMC algorithm developed here was implemented on a cluster that, depending on availability, 
permitted simultaneous calculation on 100+ processors. The particles are distributed evenly 
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across the available processors, so that calculations on many particles are ongoing in parallel. 
Only at the resampling step and in the calculations of the ESS and the ICC is information 
shared across the processors. At day 83, we are considering the batch of data for which the 
greatest computational effort is required for the SMC analysis to derive inference. Elsewhere, 
the computational benefits of SMC are more clearly observed (for example, by the end of the 
83 to 120 day interval, less than 10 iterations are required for rejuvenations). For batches of 
data that do not lead to a rejuvenation of the particle sample, the SMC updates require a 
negligible amount of time to compute and are evidently very much quicker than the MCMC 
analyses, that still have to run very long chains to produce a reasonable posterior sample. 
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Figure 7: The evolution over time of the marginal joint posterior for two components of the parameter vector 𝜷𝑩, 
comparing between SMC-obtained and MCMC-obtained posterior distributions. Grey points indicate the 
distribution at the start of the interval.
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5 Discussion 
5.1 Achievements and objectives 
The objective of this work was to advance the state of the art of real-time modelling of 
influenza epidemics and to provide a tool that could be used to monitor and predict the 
development of an ongoing pandemic outbreak.  
We have advanced the state of the art by 
1. Developing transmission models that account for spatial heterogeneity in the spread of 
infection; 
2. Improving the efficiency with which estimation and prediction of an epidemic can be 
carried out. This has been achieved through the development of a Sequential Monte 
Carlo algorithm that will greatly reduce the computational burden for routine data 
analysis as part of a program of pandemic surveillance; 
3. Facilitating the ability of the public health community to provide timely online 
inference to policymakers through provision of software to implement both of the 
above. The software has been adapted for the anticipated suite of epidemic data and 
key PHE scientists are engaged with ongoing training in its use. The computing code 
(and any related documentation) for the MCMC and SMC implementations of the 
real-time model are stored in open online repositories.55,56 
In the initial proposal, there was also a component of this research promising support to 
the HPA (now PHE) in the event of a pandemic outbreak during the scope of this grant, in 
their real-time production of estimates and projections of the healthcare burden attributable to 
the pandemic. Such an outbreak did not occur and this component of the project has thus not 
yet been activated.  
5.2 Strengths and Limitations 
5.2.1 Spatial Modelling 
This work has led to a coherent, unified, Bayesian statistical analysis of multiple streams of 
epidemic surveillance data from the 2009 A/H1N1pdm outbreak in England producing age 
and region stratified epidemic reconstructions (with associated uncertainty) and robust 
estimates of the parameters of the transmission process. We have explored two modelling 
approaches: the parallel-region (PR) and the meta-region (MR) models. Both fit adequately 
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well the various data sources, with highly comparable estimates for both model parameters 
and epidemic characteristics that are consistent with existing literature.  
Each approach has its strengths and limitations.  
The PR approach is found to be parsimonious yet sufficiently flexible to capture the 
underlying dynamics.  It is also ‘non-parametric’, in the sense that the parameters 
representing the epidemic growth and initial seeding of infectiousness in each region are 
estimated without being subject to any parametric assumption. However, this lack of linkage 
means that the spread of infection between regions cannot be forecast and significant 
epidemic activity has to be observed in all regions to enable estimation of the epidemic 
burden. This lack of predictive ability is a limitation in the use of the PR approach. However, 
the greater flexibility becomes an advantage when it comes to epidemic reconstruction and 
this is observed in a significant improvement in the model fit of the PR approach to the 2009 
pandemic data. An additional advantage is that this modelling approach does not rely on the 
validity of the commuter data to describe the spread of infection, nor does it rely on the 
assumption that individuals maintain routine commuting behaviour regardless of infection 
status. Despite the permitted spatial variation in epidemic growth rates, the PR model 
provides estimates for 𝑅"init that are consistent across regions. Therefore, the spatial 
heterogeneity in infection is being accounted for through the initial seeding of infectiousness. 
The MR model incorporates spatial heterogeneity in transmission, arising from the 
interaction between regional populations, through commuting flows. This gives the MR 
model greater power to predict the spatial spread of influenza, enabling the prediction of 
which will be the next region to experience widespread infection. Early in a pandemic, 
therefore, the MR approach is more useful in a predictive modelling setting. However, it has 
been seen elsewhere that long-range interactions have a declining role in the spread of a 
pandemic once infection is widespread in each region.57 This is exacerbated for A/H1N1pdm 
influenza as school-age children, the demographic group most affected, do not contribute to 
commuter movements. This marginalises, to some degree, the key benefit of this approach. 
Additionally, the MR approach involves an increased computational burden that limits its use 
as a tool for timely epidemic tracking as data accumulate over time. 
One variant of the MR model investigated here involved the stratification of the 
population within each region into commuters and non-commuters. This has the effect of 
assuming each region contains a fixed sub-population of individuals who commute daily. 
This formulation yields no consistent improvement in model performance, whilst increasing 
even further the computational cost. Factoring in the ‘random’ movements of casual and 
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occasional travellers, which have been quoted to potentially increase the rate of transmission 
between regions by 25%,58 would involve further computational burden and is particularly 
difficult to implement in an inferential setting without appropriate auxiliary information (e.g. 
if the census data contained information on the purpose of travel). 
The MR model could be made more realistic and detailed by assuming that a 
proportion of those with symptomatic illness may not travel, or that asymptomatic illness is 
less infectious. However, consideration of such factors would only lessen the contribution of 
long-range transmission, leaving conclusions unchanged. 
To summarise, using a Bayesian statistical framework, the PR model is found to be 
sufficiently flexible to provide a good fit to data and is quick to implement as it includes 
lower dimension contact matrices and, particularly, as the non-interacting nature of the 
regions means that the likelihood calculations can be easily parallelised. Reassuringly, it also 
provided concurring estimates for the basic reproductive number (𝑅"init) across the regions, in 
agreement with the MR approach. However, the PR model can provide little insight on inter-
region transmission and the determinants of spatial heterogeneity in the spread of infection 
because of its simple structure. In a situation where school-age children are the main agents 
of transmission and baseline transmissibility is not high, spatial models that concentrate on 
local transmission, like the PR model, provide a powerful and timely tool for use by public 
health services, helping to inform effective control and containment measures. 
 
5.2.2 Efficient estimation and prediction 
We have proposed addressing the substantive problem of real-time tracking of an emergent 
and realistic epidemic, assimilating multiple sources of information through the development 
of a suitable Sequential Monte Carlo (SMC) algorithm. When incoming data are stable, this 
process can be automated using standard algorithms in line with approaches already in the 
literature.12,27 However, in the presence of interventions or any other event that may 
artificially interrupt the epidemic’s trajectory or even result in a shock to the epidemic 
system, it is necessary to adapt the algorithm appropriately. How the algorithm is adapted 
will depend on the scale of the disruption to the surveillance data. The end result will be a 
semi-automated SMC algorithm that can be tailored to the nature of the shock to limit the 
required computation time.  
This hybrid SMC can be seen to greatly outperform MCMC when it comes to 
successively iterating analyses, as will be required in a pandemic scenario. Throughout, we 
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have compared the divergence between SMC posteriors from posteriors generated by the 
“gold standard'' MCMC.  However, this may be an unfair comparison as the MCMC 
algorithm is based on “plain vanilla'' Metropolis updates and could benefit from an in-depth 
tuning process itself. More sophisticated MCMC algorithms could be used, e.g. differential 
geometric MCMC or parallelised MCMC.59, 60. These could assist with improving MCMC 
run times. On the other hand, as MCMC steps are the main computational overhead of the 
SMC algorithm, any development of the MCMC algorithm may also lead to similar 
improvement of the SMC algorithm. It is also worth adding that the benefits of SMC for real-
time analysis have been demonstrated. For a single, one-off, analysis aimed at reconstructing 
the epidemic dynamics, the SMC algorithm would be implemented differently and may not 
hold any significant advantage over MCMC. 
Finally, the analyses carried out in this work have neglected the first fifty days of the 
epidemic, concentrating on a period when there is substantial transmission in the population 
and appropriate data are becoming available. As a result, a deterministic system can 
adequately describe the future evolution of the pandemic. Stochastic effects are significant 
and need to be incorporated into the model if monitoring is needed in the earlier stages. A 
prescription exists for what is known as “particle learning” in the presence of `shocks' in such 
a setting.61 Alternatively, to improve the robustness of the inferences, the piecewise linear 
quantities describing population reporting behaviour could be described by linked stochastic 
noise processes. This has the potential to reduce the sensitivity of estimates to the presence of 
changepoints that are not, for whatever reason, foreseeable. 
Over the course of this project, the state of the art of statistical computing in epidemic 
models has advanced in many directions, motivated by influenza and also recent Ebola 
outbreaks.11,27,62-64  Each approach, however, uses direct observations of cases or estimates of 
cases to fit models. It is believed that our approach to tackling a realistic, messy, suite of 
epidemic data is both novel and critically important. 
5.2.3 Pandemic Data 
The capacity to provide real-time estimation and prediction of an epidemic is not only 
dependent on the existence of models and software. Crucial to this ability is the richness of 
the available public health surveillance data and its timely availability. The UK is well served 
in terms of the depth and completeness of its influenza surveillance mechanisms and the 
timely availability of data can almost be guaranteed wherever it arises as a result of routine 
collection and reporting. This is not quite the case for the serological information, however, 
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which requires suitable tests to be developed, and samples to be collected and analysed. The 
role of serological data is shown in Figure 10 of Birrell et al.,47 where epidemic projections 
have been sequentially made using only noisy primary care consultation data in the absence 
of serology data. A reliable picture of the epidemic is not available until the epidemic is 
almost over. This poses some key questions: are serological samples going to be available in 
a timely manner, in sufficient quantity and quality, and in the right format? The availability 
of this data is a potentially limiting factor. 
Routine influenza surveillance data may be reliable in terms of its timely provision; it 
may become unreliable as the demands placed upon healthcare services increase as infection 
becomes more widespread. Hospital beds and GP appointments are finite and the healthcare 
system may be operating at capacity for a period. Services such as NPFS are designed to 
alleviate this burden in primary care, but, in particular, we have to entertain the possibility 
that the proportion of cases that lead to hospitalisation might diminish. The model will permit 
time variation in 𝒑R to account for these density-dependent effects, but how to diagnose and 
characterise this decline are still open problems. As will be discussed in Section 6.1.1, this 
motivates an exploration of the relationship between primary care ILI surveillance and 
community ILI surveillance. The aim is to find alternative data sources whose interpretation 
and collection is robust to high levels of influenza activity and can therefore constitute a 
valuable addition to the array of data already under consideration. 
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6 Conclusions 
6.1 Research Recommendations 
There are a number of very evident areas for future research and we summarise them briefly 
in what follows. 
6.1.1 Alternative ILI surveillance 
The majority of ILI presentations to health services will be via primary care, at least up to a 
point where a service such as the National Pandemic inFluenza Service (NPFS) is initiated. 
There are a number of potential additional surveillance systems that capture ILI occurring in 
the community, e.g. phone calls to the NHS 111 service, GP in-hours, GP out of hours, and 
RCGP spotter practices.65 Once NPFS is activated, most ILI presentations will be diverted to 
this service, with integrated self-sampling providing data on virological positivity. The model 
currently works with GP ILI diagnoses reported via GP in-hours. There is the potential to use 
an amalgamation of the available surveillance data. If this were to be considered desirable 
then further research to understand the overlap between the systems would be required as 
well as how to measure virological positivity under each of the schemes. 
 As discussed in Section 5.2.3, the reliability of the data from traditional ILI 
surveillance schemes diminishes as resources become more stretched. This may motivate the 
potential use of alternative surveillance mechanisms that are not reliant upon the allocation of 
healthcare resources. These could be through internet searches,66 social media data,67 
community reporting of symptoms,44 or even sales of thermometers.68 How to integrate these 
types of data into mechanistic models for disease transmission is still little understood and 
warrants further investigation. 
6.1.2 Incorporating Interventions 
To improve their utility as an epidemic response tool, the models presented here should be 
developed further to account for any interventions and mitigation strategies that may be 
employed during an influenza pandemic. Any interventions deployed and the strategies used 
will depend upon the nature and severity of the outbreak,69 though they fall into two 
categories: pharmaceutical interventions (e.g. antivirals, antibiotics and vaccinations); and 
non-pharmaceutical interventions (e.g. school closures and hygiene campaigns).  
The use of a pandemic specific vaccine would occur a few months after the start of 
the pandemic once a vaccine had been developed and manufactured. Vaccination has the 
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effect of changing the state of a substantial proportion of those vaccinated, the size of which 
would be dictated by the vaccine efficacy, from “susceptible” to “recovered”, making the 
vaccinated individuals bypass other states within the model. Accounting for vaccination 
would then require a modification to the transmission model structure to enable the flow of 
vaccinated individuals directly between “susceptible” and “recovered” model states. This 
flow would be informed by data on vaccine coverage and vaccine efficacy.  
A mitigation strategy that has been extensively studied is that of closures of schools. 
This strategy can be incorporated directly into the current model in manner similar to how the 
model currently handles school vacations i.e. by manipulating entries of the contact matrix 
corresponding to school age children. There are several studies that have estimated the 
changes in contact patterns during school vacations.70 However, prolonged school closures 
may lead to wider differences in contact patterns that, to our knowledge, have not been 
rigorously studied. Further research may well be required to inform how the contact matrix 
would differ from that of school holiday periods. 
Other non-pharmaceutical interventions can be used to slow the spread of infection 
and buy time for the development of biomedical interventions. These interventions may 
include hand hygiene campaigns and advice to avoid large gatherings, and they go hand-in-
hand with other events that may influence the public’s response to the pandemic, such as 
high-profile illnesses and sensationalist media reporting. These can impact upon 
transmission, but perhaps more significantly from a modelling perspective, they can influence 
how people interact with healthcare services and report their illness, affecting directly the 
data used in the modelling. Therefore, developing an understanding of these behavioural 
changes in real-time is vital to be able to estimate accurately the scale and spread of infection 
and the attached uncertainties. 
6.1.3 Stochastic Model Adaptations 
As commented in Section 5.2.2, the existing modelling approach only has utility once the 
epidemic is well established and infection is widespread. A consequence of this is that it is 
difficult to say anything about the early stages of the pandemic with any degree of certainty 
and parameters describing initial conditions of the dynamic transmission model have no real 
interpretation. Recent work by Shubin et al.71 implements a similar model to Birrell et al.15 to 
reconstruct the Finnish pandemic in 2009, with the exception that stochastic dynamics are 
used. Introducing similar stochastic dynamics in our spatial models would be of some 
interest, particularly in the MR modelling where the pattern of inter-region transmission 
69 
 
would be less rigidly defined by the commuting data. A further aspect that could be improved 
through the injection of stochasticity is the robustness of inferences. For example, parameters 
depending on the healthcare-seeking behaviour of populations could be replaced with 
stochastic noise processes. Such processes could take the form of the endemic/epidemic 
model,72 for example, and would remove the sensitivity of the estimated epidemic trajectories 
derived by the pandemic model to the choice of change points discussed in Section 5.2.2. 
Furthermore, these processes are sufficiently flexible to incorporate any information on 
external factors that may influence the healthcare-seeking behaviour of a population. 
6.1.4 Timely provision and understanding of serological data 
The role of timely serological data has been demonstrated for the 2009 pandemic. As 
discussed in Section 6.2 below, it is vital that a system should be in place that can be 
exploited promptly in the event of a pandemic to give reliable information on susceptibility to 
the pandemic strain both at the beginning and throughout an epidemic.  
It is possible that too much weight has been attributed to these data, however. 
Immunity is assumed to be present in all individuals with HI titre values above a given 
threshold. In reality, things may not be quite so well defined and it would be ideal if the 
uncertainty in determining the presence of immunity could be propagated into the analysis of 
the real-time model. This has been done in an analysis of Dutch A/H1N1pdm data, where 
protein micro arrays were used as a diagnostic assay to investigate antibody responses in 
cross-sectional serological samples.73 This provided a probabilistic statement of whether the 
individual was susceptible, recently infected or held long-standing immunity. Being able to 
incorporate this type of information into the analysis would improve the handling of 
uncertainty in the model and give a clearer picture of initial levels of susceptibility. 
6.1.5 Routine Operation 
Each autumn/winter there is an annual influenza season over which rates of infection are 
heightened. Each season is characterised by a unique blend of circulating influenza viruses, 
leading to illness of varying severity. Typically, the well of immunity in the population to the 
circulating viruses prevents an escalation to pandemic levels. However, these seasonal 
infections exert a healthcare burden and models could inform the estimation and prediction of 
such burden. Routine operation of the real-time modelling system during these seasonal 
outbreaks ahead of a possible pandemic would provide invaluable insight into algorithmic 
performance, would allow PHE end users to familiarise themselves with the software and 
epidemiologists to become familiar with the model’s data requirements. Both could then be 
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formally involved in the change process whenever the model requires adaptation in the light 
of any unforeseen operational hitches that may be identified and as the relevant surveillance 
schemes evolve. 
6.2 Implications for healthcare 
1. Continued funding to support the taking and storing of blood sera samples either via 
the existing telephone surveys, or through some other mechanism is essential. 
Without these data, primary care surveillance data are only weakly informative on the 
levels of underlying infection in the population. In many cases the peak of the 
epidemic has to be observed before it can be predicted with any confidence. These 
samples should not only be limited to being taken in-pandemic or post-pandemic. 
Storing samples from the beginning and the end of traditional flu seasons will provide 
a supply of blood sera samples to test (once an assay has been developed) that should 
be representative of the population’s initial level of susceptibility to the pandemic 
influenza strain at the start of a pandemic, a vital ingredient of the transmission 
model. Furthermore, due to the time required from the start of an outbreak to the 
development of a suitable assay it is imperative that there are no further delays in the 
provision of these data to the real-time modelling effort, such as the academic need to 
publish the data. 
2. It is essential that there is attendant virological surveillance accompanying any 
primary care data (such as GP consultations, or NPFS interactions), to separate out 
those with the pandemic infection from those with other respiratory viruses as well as 
the “worried well”. On examining the USISS hospitalisation data, it appears that there 
are many confirmed influenza admissions with missing information on the virus sub-
type. As the number of hospitalisations can often be relatively small, mis-labelling at 
this level could influence by orders of magnitude estimates for incidence. In the event 
of a pandemic, great effort should be taken to ensure that this does not occur. 
3. It is trivial to adjust the transmission model to accommodate the effects of vaccination 
and so the real-time model can provide a tool to assess the impact of any vaccination 
strategies that the government may be considering. Other pandemic interventions can 
be prospectively assessed before their implementation using inferences drawn up to 
the current time and some reasonable assumptions about the impact of the 
intervention. However, accommodating data that may arise as a result of a pandemic 
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intervention (such as data on vaccine uptake) into the real-time modelling process is 
not so straightforward and this needs to be given some serious future thought. 
4. Retention of statistical modelling expertise is essential within the responsible public 
health body (currently PHE). The statistical procedures described in this report are 
described as semi-automated, in that their performance can be improved greatly with 
user input, particularly in the presence of unforeseen epidemic events or “shocks” in 
surveillance data. Furthermore, a great deal of statistical literacy is required to be able 
to specify the model to adapt to the unique characteristics of an outbreak of a novel 
influenza virus and the relevant surveillance data that could become available in 
future.
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Appendices 
Appendix 1: Single-region model dynamics 
Assume that a population can be split into 𝐴 strata (in Birrell et al.15 these are defined by age 
groups), denoted by	𝑎	 = 	1, . . . , 𝐴. The E and I states of the SEIR-model depicted in Figure 1 
are split into two sub-states, 𝐸1, 𝐸2 and 𝐼1, 𝐼2 , to ensure that both the latent and incubation 
periods are gamma distributed, rather than exponentially distributed, where the modal time is 
zero. The infection status of the population within each stratum 𝑎 at discrete times 𝑡𝑘	 = 	𝑘𝛿𝑡, 
for 𝑘	 = 	0, . . . , 𝐾	and for appropriately small 𝛿𝑡, and 𝑘 ≥ 1 is approximated by the 
deterministic system of difference equations: 
 𝑆M(𝑡>) = 𝑆M(𝑡>^B)(1 − 𝜆M(𝑡>^B)𝛿𝑡),	𝐸B,M(𝑡>) = 𝐸B,M(𝑡>^B)(1 − 𝜎𝛿𝑡) + 𝑆M(𝑡>^B)𝜆M(𝑡>^B)𝛿𝑡,	𝐸,M(𝑡>) = 𝐸,M(𝑡>^B)(1 − 𝜎𝛿𝑡) + 𝐸B,M(𝑡>^B)𝜎𝛿𝑡,	𝐼B,M(𝑡>) = 𝐼B,M(𝑡>^B)(1 − 𝛾𝛿𝑡) + 𝐸,M(𝑡>^B)𝜎𝛿𝑡,	𝐼,M(𝑡>) = 𝐼,M(𝑡>^B)(1 − 𝛾𝛿𝑡) + 𝐼B,M(𝑡>^B)𝛾𝛿𝑡. 
(8) 
Parameters σ and γ are related to the mean durations of latent and infectious infection, 𝑑𝐿 and 
dI respectively, via σ	 = 	2/dL,γ	 = 	2/dI, and the force of infection, 𝜆M(𝑡>) is expressed 
through the Reed-Frost formulation 
 𝜆M(𝑡>) = 1 −³P(1 − 𝛽M,"(𝑡>))æ,#(kl)Ú$,#(kl)S¹"KB  (9) 
where the quantity 𝛽M,"(𝑡>) is the (𝑎, 𝑏)th entry of the (𝐴 × 𝐴) matrix 𝜷(𝑡>) and gives the 
infectious pressure exerted on a susceptible individual in stratum 𝑎 by a single infectious 
individual in stratum 𝑏. This relates to the epidemic’s reproductive number, 𝑅0 via the 
relation 
 𝜷(𝑡>) =𝑴(𝑡>) 𝑅" 𝑅"∗' 	 (10) 
where 𝑴(𝑡>) = 	 {𝑀M,"(𝑡>)} are matrices of relative infective contact rates between individual 
of age groups 𝑎 and 𝑏 derived from POLYMOD data29 and contact parameters, 𝑚à, 𝑗 =1,… , 5 that modify these contact rates to allow for increased transmissibility in contacts 
involving children and the effects of school closures (as described elsewhere15). 𝑅"∗  denotes 
the dominant eigenvalue of the time-0 next generation matrix 𝑴∗ which has (𝑎,𝑏)th entry 
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given by 𝐷M ×𝑀M,"(𝑡") × 𝑑, where 𝐷M  is the resident population size of people in age group 𝑎. 
The number of new infections at each time is then given by 
 ΔM(YZ[\])(𝑡>) = 𝑆M(𝑡>^B)𝜆M(𝑡>^B)𝛿𝑡.  (11) 
 
New symptomatic infections (however symptoms are being defined) are then given by ΔM(𝑡>) = 𝜙ΔM(YZ[\])(𝑡>), where 𝜙 is the proportion of infections that are symptomatic (see 
Figure 1). 
 In all of what follows, 𝛿𝑡=0.5 days, a duration sufficiently small relative to the 
expected waiting times in each of the model states. With this choice, the dynamics mapped 
out by the difference equations in (8) are a close match to the differential equation system 
that they are designed to replicate. 
 
Parallel-region (PR) model 
The equations in the PR model are exactly the same, except that we repeat the system of 
Equations in (8) for each region, and denote the region by 𝑟 = 1,… , 𝑅: 
 𝑆M,6(𝑡>) = 𝑆M,6(𝑡>^B)w1 − 𝜆M,6(𝑡>^B)𝛿𝑡x,	𝐸B,M,6(𝑡>) = 𝐸B,M,6(𝑡>^B)(1 − 𝜎𝛿𝑡) + 𝑆M,6(𝑡>^B)𝜆M,6(𝑡>^B)𝛿𝑡,	𝐸,M,6(𝑡>) = 𝐸,M,6(𝑡>^B)(1 − 𝜎𝛿𝑡) + 𝐸B,M,6(𝑡>^B)𝜎𝛿𝑡,	𝐼B,M,6(𝑡>) = 𝐼B,M,6(𝑡>^B)(1 − 𝛾𝛿𝑡) + 𝐸,M,6(𝑡>^B)𝜎𝛿𝑡,	𝐼,M,6(𝑡>) = 𝐼,M,6(𝑡>^B)(1 − 𝛾𝛿𝑡) + 𝐼B,M,6(𝑡>^B)𝛾𝛿𝑡. 
(12) 
with Equations (9) and (10) being similarly adapted: 
 𝜆M,6(𝑡>) = 1 −³ )m1 − 𝛽M,",6(𝑡>)oæ,#,*(kl)Ú$,#,*(kl)+¹"KB ,  𝜷6(𝑡>) = 𝑴(𝑡>) 𝑅",, 𝑅",6∗- , 
where, again the quantity 𝛽M,",6(𝑡>) is the (𝑎, 𝑏)th entry of the (𝐴 × 𝐴) matrix 𝜷6(𝑡>).  
Meta-region (MR) model 
Superficially, the system of equations governing the SEIR dynamics is the same as presented 
in the equation block (8). The subtle difference is that the stratum indicator 𝑎 now takes 
values in the range 1,… , 𝑅𝐴. Similarly to Equation (9), the force of infection is given by 
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 𝜆M(𝑡>) = 1 −³ )m1 − 𝛽M,"(𝑡>)oæ,#(kl)Ú$,#(kl)+J¹"KB .  
Each of the 𝑅𝐴 strata corresponds to a unique pairing of region 𝑟 and age group 𝑎’, (𝑟, 𝑎’). 
Therefore, a stratum number can be assigned by setting 𝑎	 = 𝑎’+ 𝐴(𝑟 − 1). Considering two 
such strata 𝑎 and 𝑏, the infection rate matrix has entries 𝛽M,"(𝑡>) = 	ΠM,"(𝑡>) × 𝑅" 𝑅"∗' , 
where ΠM,"(𝑡>) are entries of the meta-region contact matrix 𝚷(𝑡>). The (𝑅𝐴 × 𝑅𝐴) matrices, 𝚷(𝑡>) have a necessarily different structure to the contact matrices used in the single-region 
model or the PR model. As discussed in Section 3.2.2, the entries of these matrices that 
correspond to contacts between individuals resident in different regions have been informed 
on the basis of commuter data from the ONS’ 2001 UK census data collection. These data 
come in the form of matrices, 𝑪(𝑎′), 𝑎′ = 1,… , 𝐴 that have (𝑟, 𝑠) entry 𝐶6E(𝑎′), for 𝑟, 𝑠 =1,… , 𝑅. These matrix entries represent the proportion of age group 𝑎 who are resident in 
region 𝑟 that commute into region 𝑠 on any given day (see Table 8). However, it is assumed 
that individuals younger than 16 years old do not commute, leading to the white sections in 
Figure 2. 
Table 8: Commuter matrices. For each of the four adult age groups, cells give the proportion of individuals resident 
in each region (by row), who move to (or stay in) each of the four regions (columns). Reproduced from Birrell et al.28 Matrix	Crs	(a)	 London	 WM	 North	 South	 London	 WM	 North	 South	Ages:	16-24	years	 Ages:	25-44	years	London	 93.50%	 0.11%	 0.30%	 6.12%	 92.10%	 0.11%	 0.26%	 7.54%	WM	 0.43%	 95.60%	 2.29%	 1.64%	 0.52%	 94.80%	 2.95%	 1.71%	North	 0.36%	 0.77%	 97.30%	 1.57%	 0.46%	 0.99%	 96.90%	 1.67%	South	 5.09%	 0.22%	 0.45%	 94.20%	 9.29%	 0.30%	 0.53%	 89.90%		 Ages:	45-64	years	 Ages:	65-74	years	London	 93.60%	 0.10%	 0.24%	 6.10%	 85%	 0.11%	 0.23%	 14.60%	WM	 0.37%	 96%	 2.32%	 1.31%	 0.35%	 97.40%	 1.41%	 0.85%	North	 0.35%	 0.83%	 97.80%	 1.06%	 0.34%	 0.47%	 98.50%	 0.65%	South	 6.87%	 0.27%	 0.46%	 92.40%	 4%	 0.19%	 0.33%	 95.50%	
Commuter movements are assumed to cover a fraction of the total time equal to 𝜉, and inter-
region transmission is only possible in this proportion of time. Assuming, then, that 
commuting movements all take place at the same time, an individual belonging to a strata 𝑎 
that corresponds to the region/age-group pairing of (𝑟, 𝑎’) will be in the same region as an 
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individual from strata 𝑏 (corresponding to (𝑠,𝑏’)), with probability ∑ 𝐶6,z(𝑎=)𝐶E,z(𝑏=)JzKB . To 
get a probability of contact between the two individuals, we might need to scale the terms in 
the sum according to the density dependence assumptions. It is assumed that once in a region, 
individuals will associate with members of other age groups according to the POLYMOD-
based matrices used in the single-region and PR models. Therefore, the meta-region contact 
matrices 𝚷(𝑡>) is constructed to have entries 
 ΠM,"(𝑡>) = 𝑀M>,">(𝑡>) ?(1 − 𝜉)𝛿6Ew𝐷6,M>ð x@ + 𝜉U𝐶6z(𝑎=)𝐶Ez(𝑏=)w𝐷z,M>A x@JzKB B. (13) 
The 𝐷6,M>ð = 𝐷6,M> are the population sizes for the (𝑟, 𝑎’) stratum at night (i.e. the size of the 
resident population) and 𝐷6,M>A  are the daytime population sizes, the adjusted population sizes 
after commuter movements have taken place, 	𝐷6,M>C = ∑ 𝐶E6(𝑎′)𝐷E,M>JEKB . The proportion of 
total time that a commuter actually spends in the commuting region is taken to be 𝜉 = 5/14 
on the basis of a daily average of five working days per week, being away from home for a 
half day when working. The exponent 𝛼 takes values in [0,1] with a value of 0 indicating 
frequency-driven transmission and 1, density-driven transmission; 𝛿6E is merely a Kronecker-
delta function. It is furthermore important to note that under this model, the 𝑅"∗ is calculated 
on the basis of the next-generation matrix 𝚷∗, with entries ΠM,"∗ = 𝐷6,M>ΠM,"(𝑡")𝑑, with the 
various strata being as defined above. It is easy to see how the block-diagonal structure of 
these matrices arrives, as within these blocks, 𝑟 = 𝑠 and the left-hand term within the 
bracketed sum contributes to the contact rates. 
 The denominators of Equation (13) give the prevalent degree of density dependence. 
There are two things to consider here: 
• The value of 𝛼. A value of 𝛼 = 0 corresponds to frequency dependent transmission 
(two people are equally like to interact regardless of the population size of their 
strata), whereas 𝛼 = 1 corresponds to a density dependent effect upon transmission. 
Values of 𝛼 = 0, 0.5, and 1 will be considered. 
• How density dependence should be incorporated. Equation (13) uses dependence 
upon the population size of the strata of the uninfected individual in an infectious 
contact. However, it seems more logical to use the population size of the region to 
which the infectious individual belongs. This is more comparable to the PR model 
that assumes no density dependent effects across the age groups. Therefore, as an 
alternative, it is proposed to replace 𝐷6,Mð  with the region-wide population size 𝐷zð =
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∑ 𝐷z,Mð¹MKB  and 𝐷6,MA  with 𝐷zA = ∑ 𝐷z,MA¹MKB . This tests whether it is the population size 
of a region that is important in density dependence, as opposed to the age-group 
constitution of that population. 
 
Another modelling feature to be tested through the specification of the contact matrix in 
the MR model is the random commuter model formulation vs. the fixed commuter 
formulation. However the strata are defined, individuals within each stratum are assumed to 
be homogeneous of behavior. That is, in any given interval, any individual within a specific 
stratum is equally likely to be one who commutes. This may well prove to be a gross 
simplification because: 
• The bulk of commuting is done by a much smaller sub‐population within a stratum, 
each of who commutes on a regular basis. 
• Infectious individuals are still assumed to carry on with normal commuting behaviour, 
whereas in reality, they may well be too ill to travel. 
The first simplification we term to be an assumption of ‘commuting at random’. To consider 
the possibility that there is a fixed sub-population within each stratum that commute 
regularly, we further stratify the adult age groups into ‘commuters’ and ‘non-commuters’. 
Commuters are assumed not to stay in their home region during working hours, whereas non-
commuters stay in the  region in which they are resident with certainty. So, rather than 𝑅𝐴 
strata (in the 2009 A/H1N1pdm example, this is 7 × 4 = 28), we partition further. Four of 
the seven age groups are of adult-age individuals and can be further divided into commuter 
and non-commuter classes. Therefore we now consider (𝐴 + 4) × 𝑅 = 44 strata. In this 
example, the expanded matrix has an identical mathematical expression as before (Equation 
(13)), once the 𝐶6E(𝑎) are replaced by 𝐶6E= (𝑎), where 
 𝐶66= (𝑎) = D1, 𝑎	belongs	to	a	non-commuter	class0, 𝑎	belongs	to	a	commuter	class  
𝐶6E= (𝑎) = F 0												, 𝑎	belongs	to	a	non-commuter	class𝐶6E(𝑎)1 −	𝐶66(𝑎) , 𝑎	belongs	to	a	commuter	class.  
 
 The assumption of commuting at random speeds up the spread of infection across the 𝐴 regions while the fixed commuting assumption increases the transiency of any commuting 
effects and results in greater heterogeneity in the times of peak infection across the regions. 
However, simulations have shown that the peak size and attack rate are	insensitive	to	the	commuting	assumption. 
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Appendix 2: Single-region model dynamics 
Below is an itemised list of model parameters, giving for each a symbol, a short description 
of the role of the parameter and the types of heterogeneity in the value of the parameter that 
the real-time model software can accommodate. 
 𝜂 The over-dispersion inherent in the GP consultation counts. Only relevant if the 
selected likelihood is negative-binomial and not Poisson. Region-, time- and strata-
specific variation permitted. 𝑑Ü The expected duration of the latent stage of infection. Region-, time- and strata-
specific variation permitted. 𝑑 The expected duration of the infectious stage of infection. Region-, time- and 
strata-specific variation permitted. 𝜀 The relative infectiousness of state 𝐼 to state 𝐼B. If not equal to 1, replace, in 
Equation (9), 𝐼B,"(𝑡>) + 𝐼,"(𝑡>) with 𝐼B,"(𝑡>) + 𝜀𝐼,"(𝑡>). Region-, time- and 
strata-specific variation permitted. 𝜙 The proportion of infections that develop the specific syndromic symptoms (e.g. ILI 
symptoms). Region-, time- and strata-specific variation permitted. 𝑚 Multiplicative modifiers of the contact matrices. Can apply to any times or strata, but 
must apply equally across each region. 𝑘¹ Parameter describing the amplitude of oscillation of R0. The time evolution of R0 is 
given by 𝑅"(𝑡) = 𝑅"init + 𝐴J ~cos~2𝜋(𝑡 + 𝑠𝑑 − 𝑝𝑑)365.25  − cos~2𝜋(𝑠𝑑 − 𝑝𝑑)365.25 . 
Here 𝐴J  is the amplitude of oscillation for 𝑅", 𝑠𝑑 is the day of the year 
corresponding to day 1 of the epidemic and 𝑝𝑑 is the day upon which 𝑅" is expected 
to peak. To ensure positive values for 𝑅", 𝑘¹ takes values in [0,1) and is such that 𝐴J = 𝑘¹𝑅"init1 −	cos(2𝜋(𝑠𝑑 − 𝑝𝑑)/365.25) 
This parameter has no permitted regional, temporal or strata-specific variation. 𝜓 Exponential growth rates for the initial stage of the epidemic. Reparameterisation of 𝑅"init, to a parameter more readily identifiable from data. 
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𝑅"init = 𝜓𝑑 m𝜓𝑑Ü2 + 1o1 − 1m𝜓𝑑2 + 1o
 
Regional variation only allowed. 𝜐 Reparameterisation of the initial number of infectives, used to seed each region, such 
that 𝜐 and 𝐼"are related by 𝐼" = 𝑑𝑒I ∑ 𝑁MM𝑝Bf(𝑡")𝑅"init 
Regional variation only allowed. 𝜌 Initial proportion of the population susceptible to infection. An initial condition, so 
regional- and strata-specific variation allowed. 𝑝f Proportion of symptomatic cases that will end up in the GP consultation dataset. 
Region-, time- and strata-specific variation permitted. 𝑝R Proportion of symptomatic cases that will end up in the USISS hospital dataset. 
Region-, time- and strata-specific variation permitted. 𝐵 Parameters describing the rates of non-pandemic ILI GP consultation. Region-, 
time- and strata-specific variation permitted. 𝑘sens Test sensitivity of the virological swabbing process. No variation presently 
permitted. 𝑘spec Test specificity of the virological swabbing process. No variation presently 
permitted. 𝜅j Day of the week effects on the reporting of GP consultations. Region-, time- and 
strata-specific variation permitted. 
89 
 
Appendix 3: Goodness-of-fit plots for the PR model 
Presented here are plots of the goodness-of-fit of the PR model to the GP consultation data, 
the serological data and the virological data (in all regions except the North where 
denominators were frequently too small to get a reasonable comparison). 
 
Figure 8 Goodness-of-fit of the PR model to the GP consultation data, aggregated by age. Red +'s indicate the 
observed numbers. The darker shaded area represent the 95% CrI for the expected number of consultations, the 
wider, lighter grey interval gives a poster predictive 95% CrI for the observed data – i.e. 95% of the data points 
should lie within the wider interval over time. Adapted from Birrell et al.28 
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Figure 9 Goodness-of-fit of the PR model to the serological data, stratified by age and region. Data points are marked 
by the dots, with blue dots being those that are omitted by the model prectied 95% CrIs given by the vertical dashed 
lines. Adapted from Birrell et al.28 
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Figure 10: Goodness-of-fit of the PR model to the weekly-aggregated viropositivity data, stratified by age in London. 
Data points are given by the dots of variable width and colour. The width indicates the size of the denominator 
relative to other points in the sample plot. The colour of the points indicates the overall size of the denominator, with 
dark red points being those of largest sample size. The light grey vertical lines give a containing 95% CrI for the data 
points under the model. Adapted from Birrell et al.28 
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       Figure 11 Goodness-of-fit of the PR model to the weekly-aggregated viropositivity data, stratified by age in the 
West Midlands. See Figure D3 for greater detail. Adapted from Birrell et al.28 
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  Figure 12 Goodness-of-fit of the PR model to the weekly-aggregated viropositivity data, stratified by age, in the 
South. See Figure D3 for greater details. Adapted from Birrell et al.28
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Appendix 4: Goodness-of-fit plots for the MR model 
Presented here are plots of the goodness-of-fit of the best-fitting MR model to the GP 
consultation data, the serological data and the virological data (in all regions except the North 
where denominators were frequently too small to get a reasonable comparison). 
 
Figure 13 Goodness-of-fit of the MR model to the GP consultation data, aggregated by age. Red +'s indicate the 
observed number of consultations. The darker shaded area represent the 95% CrI for the expected number of 
consultations, the wider, lighter grey interval gives a posterior predictive 95% CrI for the observed data – i.e. 95% of 
the data points should lie within this wider interval. Adapted from Birrell et al.28 
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Figure 14 Goodness-of-fit of the MR model to the serological data, stratified by age and region. Data points are 
marked by dots, with blue dots being those that are omitted by the model predicted 95% CrIs shown by the vertical 
dashed lines. Adapted from Birrell et al.28 
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Figure 15: Goodness-of-fit of the MR model to the weekly-aggregated viropositivity data, stratified by age in London. 
Data points are given by the dots of variable width and colour. The width indicates the size of the denominator 
relative to other points in the same plot. The colour of the points indicates the overall size of the denominator, with 
dark red points being those of largest sample size. The light grey vertical lines give a containing 95% CrI for the data 
points under the model. Adapted from Birrell et al.28 
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Figure 16 Goodness-of-fit of the MR model to the weekly-aggregated viropositivity data, stratified by age, in the West 
Midlands. See Figure D3 for greater detail.28 
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Figure 17: Goodness-of-fit of the MR model to the weekly-aggregated viropositivity data, stratified by age, in the 
South. See Figure D3 for greater detail.28
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Appendix 5: Age-specific attack rates 
Table 9 Age-specific attack rates. Tables give posterior median (and 95% CrIs) for the age-specific attack rates in 
each region in both waves of the 2009 pandemic. A) presents the posterior statistics from fitting the parallel-region 
model; and B) for the meta-region model. The last column gives attack rates averaged over four regions, weighted in 
accordance with the respective population sizes.28 
A) Parallel region model  
First wave (to 
end-Aug) London West Midlands North South England 
Overall 13.2(11.4,14.9) 9.8(8.5,11.2) 5.6(4.4,6.9) 3.6(2.9,4.5) 6.4(5.8,7.1) 
<1y 18.7(16.2,21.1) 13.6(11.8,15.4) 8.0(6.4,10.0) 5.2(4.2,6.5) 9.7(8.7,10.6) 
1-4 y 29.4(25.4,33.1) 22.1(19.2,25.1) 13.2(10.4,16.5) 8.7(7.0,10.8) 15.3(13.6,17.1) 
5-14y 28.4(25.0,31.4) 24.1(21.4,27.0) 13.0(10.4,16.0) 9.0(7.2,11.0) 14.9(13.5,16.4) 
15-24y 11.9(10.0,13.6) 9.2(7.8,10.7) 5.6(4.4,7.0) 3.4(2.7,4.2) 6.1(5.4,6.9) 
25-44y 13.0(11.1,14.8) 9.6(8.3,11.2) 5.6(4.5,7.1) 3.7(2.9,4.5) 6.7(6.0,7.5) 
45-64y 7.0(5.9,8.1) 5.2(4.4,6.1) 3.1(2.4,3.9) 2.0(1.6,2.4) 3.4(3.0,3.8) 
65+y 3.5(2.9,4.0) 2.9(2.4,3.4) 1.6(1.3,2.1) 1.1(0.8,1.3) 1.8(1.5,2.0) 
Second wave (Sep.-Dec.) 
Overall 10.1(8.5,11.9) 10.6(9.0,12.2) 19.3(17.8,21.0) 19.6(18.3,21.0) 17.1(16.2,18.3) 
<1y 13.7(11.5,16.2) 13.7(11.5,15.7) 25.6(23.6,27.6) 26.2(24.6,27.9) 22.3(21.1,23.7) 
1-4 y 17.1(14.1,20.7) 18.7(15.6,21.8) 34.8(31.8,37.9) 36.7(34.3,39.2) 30.7(28.9,32.8) 
5-14y 24.9(21.0,29.3) 29.2(24.9,33.5) 50.4(46.8,53.9) 53.5(50.6,56.1) 45.6(43.5,47.7) 
15-24y 9.5(7.9,11.2) 10.0(8.4,11.6) 19.4(17.6,21.3) 18.8(17.3,20.6) 16.7(15.5,18.2) 
25-44y 9.5(7.9,11.2) 9.0(8.4,11.5) 18.6(16.9,20.4) 18.8(17.4,20.4) 16.0(15.0,17.4) 
45-64y 5.4(4.5,6.4) 5.5(4.7,6.5) 10.7(9.7,11.8) 10.5(9.7,11.6) 9.4(8.7,10.3) 
65+y 3.4(2.8,4.0) 3.6(3.1,4.2) 6.9(6.3,7.6) 6.9(6.3,7.5) 6.1(5.7,6.7) 	
B) Meta-region model 
First wave (to 
end-Aug) London West Midlands North South England 
Overall 9.9(8.9,11.0) 12.4(11.5,13.3) 4.7(4.2,5.2) 6.0(5.4,6.6) 6.8(6.1,7.4) 
<1y 14.0(12.6,15.4) 16.9(15.7,18.1) 6.5(5.8,7.2) 8.4(7.6,9.3) 9.7(8.8,10.6) 
1-4 y 20.6(17.9,23.4) 25.4(22.6,28.0) 9.9(8.4,11.4) 12.7(11.0,14.5) 14.4(12.5,16.3) 
5-14y 20.8(19.0,22.7) 29.6(27.6,31.6) 10.4(9.5,11.5) 13.8(12.6,15.1) 15.3(14.0,16.6) 
15-24y 9.3(8.1,10.5) 12.2(11.2,13.3) 4.9(4.3,5.6) 6.0(5.4,6.8) 6.7(6.0,7.5) 
25-44y 10.0(8.9,11.2) 12.5(11.6,13.6) 4.9(4.3,5.4) 6.4(5.7,7.1) 7.1(6.4,7.9) 
45-64y 5.4(4.8,6.1) 7.0(6.4,7.6) 2.7(2.4,3.1)  3.5(3.1,3.9) 3.8(3.4,4.3) 
65+y 2.7(2.3,3.0) 4.0(3.6,4.3) 1.4(1.3,1.6) 1.9(1.7,2.2) 2.0(1.8,2.3) 
Second wave (Sep.-Dec.) 
Overall 16.2(14.9,17.6) 8.9(7.5,10.4) 20.6(19.6,21.7) 18.0(17.0,19.0) 17.8(16.7,18.9) 
<1y 21.7(19.9,23.5) 11.1(9.4,13.0) 26.7(25.4,28.0) 23.5(22.1,24.8) 23.0(21.6,24.4) 
1-4 y 28.0(25.2,30.9) 15.1(12.5,18.0) 37.0(35.0,39.2) 32.6(30.4,34.8) 31.5(29.3,33.8) 
5-14y 36.7(34.0,39.5) 22.0(18.8,25.5) 51.8(50.2,53.5) 46.7(44.7,48.6) 44.5(42.5,46.6) 
15-24y 15.8(14.5,17.3) 9.0(7.6,10.6) 21.2(19.7,22.6) 17.9(16.7,19.3) 17.9(16.6,19.3) 
25-44y 15.6(14.3,17.0) 8.7(7.3,10.2) 20.2(18.9,21.4) 17.7(16.5,18.9) 17.3(16.0,18.5) 
45-64y 9.1(8.3,10.0) 5.0(4.2,5.9) 11.7(10.8,12.6) 10.2(9.4,11.0) 10.1(9.3,10.9) 
65+y 5.6(5.1,6.2) 3.3(2.7,3.9) 7.6(7.0,8.1) 6.7(6.2,7.2) 6.5(6.0,7.1) 	
